BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7. [PMID: 10973318 DOI: 10.1038/79690] [Cited by in Crossref: 1341] [Cited by in F6Publishing: 1194] [Article Influence: 61.0] [Reference Citation Analysis]
Number Citing Articles
1 Faraco J, Mignot E. Genetics of Narcolepsy. Sleep Medicine Clinics 2011;6:217-28. [DOI: 10.1016/j.jsmc.2011.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Dye TJ, Gurbani N, Simakajornboon N. Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev 2018;25:14-8. [PMID: 28108192 DOI: 10.1016/j.prrv.2016.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
3 Fernø J, Señarís R, Diéguez C, Tena-Sempere M, López M. Orexins (hypocretins) and energy balance: More than feeding. Mol Cell Endocrinol 2015;418 Pt 1:17-26. [PMID: 26213323 DOI: 10.1016/j.mce.2015.07.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bergman JM, Roecker AJ, Mercer SP, Bednar RA, Reiss DR, Ransom RW, Meacham Harrell C, Pettibone DJ, Lemaire W, Murphy KL, Li C, Prueksaritanont T, Winrow CJ, Renger JJ, Koblan KS, Hartman GD, Coleman PJ. Proline bis-amides as potent dual orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:1425-30. [DOI: 10.1016/j.bmcl.2008.01.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
5 Caylak E. The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Genet A 2009;149A:2612-26. [PMID: 19876894 DOI: 10.1002/ajmg.a.33087] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
6 Juvodden HT, Alnæs D, Lund MJ, Agartz I, Andreassen OA, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives. Sleep 2018;41. [DOI: 10.1093/sleep/zsy145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Alaez C, Lin L, Flores-A H, Vazquez M, Munguia A, Mignot E, Haro R, Baker H, Gorodezky C. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Med Genet 2008;9:79. [PMID: 18706091 DOI: 10.1186/1471-2350-9-79] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
8 Duffet L, Kosar S, Panniello M, Viberti B, Bracey E, Zych AD, Radoux-Mergault A, Zhou X, Dernic J, Ravotto L, Tsai YC, Figueiredo M, Tyagarajan SK, Weber B, Stoeber M, Gogolla N, Schmidt MH, Adamantidis AR, Fellin T, Burdakov D, Patriarchi T. A genetically encoded sensor for in vivo imaging of orexin neuropeptides. Nat Methods 2022;19:231-41. [PMID: 35145320 DOI: 10.1038/s41592-021-01390-2] [Reference Citation Analysis]
9 Wieczorek S, Gencik M, Rujescu D, Tonn P, Giegling I, Epplen J, Dahmen N. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens 2003;61:437-42. [DOI: 10.1034/j.1399-0039.2003.00068.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
10 Hintze JP, Paruthi S. Sleep in the Pediatric Population. Sleep Medicine Clinics 2016;11:91-103. [DOI: 10.1016/j.jsmc.2015.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Jones BE. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 2005;26:578-86. [PMID: 16183137 DOI: 10.1016/j.tips.2005.09.009] [Cited by in Crossref: 367] [Cited by in F6Publishing: 341] [Article Influence: 21.6] [Reference Citation Analysis]
12 Cai J, Cooke FE, Sherborne BS. Antagonists of the orexin receptors. Expert Opinion on Therapeutic Patents 2006;16:631-46. [DOI: 10.1517/13543776.16.5.631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
13 Chan A, Li S, Lee AR, Leung J, Yip A, Bird J, Godden KE, Martinez-gonzalez D, Rattenborg NC, Balaban E, Pompeiano M. Activation of state-regulating neurochemical systems in newborn and embryonic chicks. Neuroscience 2016;339:219-34. [DOI: 10.1016/j.neuroscience.2016.09.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Malherbe P, Borroni E, Gobbi L, Knust H, Nettekoven M, Pinard E, Roche O, Rogers-Evans M, Wettstein JG, Moreau JL. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 2009;156:1326-41. [PMID: 19751316 DOI: 10.1111/j.1476-5381.2009.00127.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
15 Satoh S, Matsumura H, Nakajima T, Nakahama K, Kanbayashi T, Nishino S, Yoneda H, Shigeyoshi Y. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons. Eur J Neurosci 2003;17:1635-45. [PMID: 12752381 DOI: 10.1046/j.1460-9568.2003.02577.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
16 Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
17 Ono D, Yamanaka A. Hypothalamic regulation of the sleep/wake cycle. Neurosci Res 2017;118:74-81. [PMID: 28526553 DOI: 10.1016/j.neures.2017.03.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
18 Walterfang M, Upjohn E, Velakoulis D. Is Schizophrenia Associated with Narcolepsy? Cognitive and Behavioral Neurology 2005;18:113-8. [DOI: 10.1097/01.wnn.0000160822.53577.2c] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
19 Roman A, Meftah S, Arthaud S, Luppi P, Peyron C. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep. Sleep 2018;41. [DOI: 10.1093/sleep/zsy046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
20 Boss C, Roch C. Orexin research: patent news from 2016. Expert Opinion on Therapeutic Patents 2017;27:1123-33. [DOI: 10.1080/13543776.2017.1344221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
21 Winrow CJ, Renger JJ. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol 2014;171:283-93. [PMID: 23731216 DOI: 10.1111/bph.12261] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 10.8] [Reference Citation Analysis]
22 Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 2004;82:510-29. [PMID: 15175861 DOI: 10.1007/s00109-004-0552-1] [Cited by in Crossref: 215] [Cited by in F6Publishing: 194] [Article Influence: 11.9] [Reference Citation Analysis]
23 Henny P, Jones BE. Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol 2006;499:645-61. [PMID: 17029265 DOI: 10.1002/cne.21131] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
24 Hasegawa E, Maejima T, Yoshida T, Masseck OA, Herlitze S, Yoshioka M, Sakurai T, Mieda M. Serotonin neurons in the dorsal raphe mediate the anticataplectic action of orexin neurons by reducing amygdala activity. Proc Natl Acad Sci U S A 2017;114:E3526-35. [PMID: 28396432 DOI: 10.1073/pnas.1614552114] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 8.6] [Reference Citation Analysis]
25 Liguori G, Paino S, Mirabella N, Squillacioti C, De Luca A, Vittoria A. Expression of Orexin A and its Receptor 1 in the Epididymis of the South American Camelid Alpaca ( Vicugna pacos ). Anat Histol Embryol 2014;43:42-7. [DOI: 10.1111/ahe.12046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
26 Yamasaki M, Miyagawa T, Toyoda H, Khor S, Liu X, Kuwabara H, Kano Y, Shimada T, Sugiyama T, Nishida H, Sugaya N, Tochigi M, Otowa T, Okazaki Y, Kaiya H, Kawamura Y, Miyashita A, Kuwano R, Kasai K, Tanii H, Sasaki T, Honda Y, Honda M, Tokunaga K. Evaluation of polygenic risks for narcolepsy and essential hypersomnia. J Hum Genet 2016;61:873-8. [DOI: 10.1038/jhg.2016.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
27 Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, Nishino S, Mignot E, Shiromani PJ. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27:851-6. [PMID: 15453542 DOI: 10.1093/sleep/27.5.851] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
28 Dauvilliers Y, Barateau L. Narcolepsy and Other Central Hypersomnias. Continuum (Minneap Minn) 2017;23:989-1004. [PMID: 28777172 DOI: 10.1212/CON.0000000000000492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
29 Jennum P, Ibsen R, Petersen ER, Knudsen S, Kjellberg J. Health, social, and economic consequences of narcolepsy: A controlled national study evaluating the societal effect on patients and their partners. Sleep Medicine 2012;13:1086-93. [DOI: 10.1016/j.sleep.2012.06.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
30 Kim SJ, Lyoo IK, Lee YS, Lee J, Yoon SJ, Kim JE, Kim JH, Hong SJ, Jeong D. Gray matter deficits in young adults with narcolepsy. Acta Neurologica Scandinavica 2009;119:61-7. [DOI: 10.1111/j.1600-0404.2008.01063.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
31 Taiwo OB, Russell IJ, Mignot E, Lin L, Michalek JE, Haynes W, Xiao Y, Zeitzer JM, Larson AA. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome. Sleep Medicine 2007;8:260-5. [DOI: 10.1016/j.sleep.2006.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Aissaoui H, Koberstein R, Zumbrunn C, Gatfield J, Brisbare-roch C, Jenck F, Treiber A, Boss C. N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5729-33. [DOI: 10.1016/j.bmcl.2008.09.079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
33 van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. Sleep 2016;39:1951-9. [PMID: 27568806 DOI: 10.5665/sleep.6222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
34 Dauvilliers Y, Jaussent I, Lecendreux M, Scholz S, Bayard S, Cristol JP, Blain H, Dupuy AM. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav Immun 2014;37:260-6. [PMID: 24394344 DOI: 10.1016/j.bbi.2013.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
35 Ruppert E, Zagala H, Chambe J, Comtet H, Kilic-Huck U, Lefebvre F, Bataillard M, Schroder C, Calvel L, Bourgin P. Intravenous Immunoglobulin Therapy Administered Early after Narcolepsy Type 1 Onset in Three Patients Evaluated by Clinical and Polysomnographic Follow-Up. Behav Neurol 2018;2018:1671072. [PMID: 30410634 DOI: 10.1155/2018/1671072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Beltrán E, Nguyen XH, Quériault C, Barateau L, Dauvilliers Y, Dornmair K, Liblau RS. Shared T cell receptor chains in blood memory CD4+ T cells of narcolepsy type 1 patients. J Autoimmun 2019;100:1-6. [PMID: 30948158 DOI: 10.1016/j.jaut.2019.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Oberle D, Pavel J, Mayer G, Geisler P, Keller-Stanislawski B; German Narcolepsy Study Group. Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany. Sleep Med 2017;34:71-83. [PMID: 28522102 DOI: 10.1016/j.sleep.2017.02.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
38 Nishino S, Okuro M, Kotorii N, Anegawa E, Ishimaru Y, Matsumura M, Kanbayashi T. Hypocretin/orexin and narcolepsy: new basic and clinical insights. Acta Physiol (Oxf) 2010;198:209-22. [PMID: 19555382 DOI: 10.1111/j.1748-1716.2009.02012.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
39 Sadam H, Pihlak A, Kivil A, Pihelgas S, Jaago M, Adler P, Vilo J, Vapalahti O, Neuman T, Lindholm D, Partinen M, Vaheri A, Palm K. Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling. EBioMedicine 2018;29:47-59. [PMID: 29449194 DOI: 10.1016/j.ebiom.2018.01.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
40 Xu X, Wells AB, O'Brien DR, Nehorai A, Dougherty JD. Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders. J Neurosci 2014;34:1420-31. [PMID: 24453331 DOI: 10.1523/JNEUROSCI.4488-13.2014] [Cited by in Crossref: 157] [Cited by in F6Publishing: 105] [Article Influence: 19.6] [Reference Citation Analysis]
41 Thompson MD, Sakurai T, Rainero I, Maj MC, Kukkonen JP. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics. Pharmaceuticals (Basel) 2017;10:E79. [PMID: 28991183 DOI: 10.3390/ph10040079] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
42 Lecendreux M, Churlaud G, Pitoiset F, Regnault A, Tran TA, Liblau R, Klatzmann D, Rosenzwajg M. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PLoS One 2017;12:e0169836. [PMID: 28107375 DOI: 10.1371/journal.pone.0169836] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
43 Williams RH, Burdakov D. Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 2008;10:e28. [PMID: 18828950 DOI: 10.1017/S1462399408000823] [Cited by in Crossref: 59] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
44 Fuller DE, Hornfeldt CS. From Club Drug to Orphan Drug: Sodium Oxybate (Xyrem) for the Treatment of Cataplexy. Pharmacotherapy 2003;23:1205-9. [DOI: 10.1592/phco.23.10.1205.32756] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
45 Oikonomou G, Prober DA. Attacking sleep from a new angle: contributions from zebrafish. Curr Opin Neurobiol 2017;44:80-8. [PMID: 28391131 DOI: 10.1016/j.conb.2017.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
46 Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-Wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D. Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials. J Clin Sleep Med 2016;12:1215-25. [PMID: 27397664 DOI: 10.5664/jcsm.6116] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
47 Wing YK, Li RH, Lam CW, Ho CK, Fong SY, Leung T. The prevalence of narcolepsy among Chinese in Hong Kong. Ann Neurol 2002;51:578-84. [PMID: 12112103 DOI: 10.1002/ana.10162] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
48 Richardson KA, Aston-Jones G. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J Neurosci 2012;32:3809-17. [PMID: 22423101 DOI: 10.1523/JNEUROSCI.3917-11.2012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
49 Bergen AW, van den Bree MBM, Yeager M, Welch R, Ganjei JK, Haque K, Bacanu S, Berrettini WH, Grice DE, Goldman D, Bulik CM, Klump K, Fichter M, Halmi K, Kaplan A, Strober M, Treasure J, Woodside B, Kaye WH. Candidate genes for anorexia nervosa in the 1p33–36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 2003;8:397-406. [DOI: 10.1038/sj.mp.4001318] [Cited by in Crossref: 103] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
50 Schughart K, Libert C, Kas MJ; SYSGENET consortium. Controlling complexity: the clinical relevance of mouse complex genetics. Eur J Hum Genet 2013;21:1191-6. [PMID: 23632795 DOI: 10.1038/ejhg.2013.79] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
51 Schrölkamp M, Jennum PJ, Gammeltoft S, Holm A, Kornum BR, Knudsen S. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2. J Clin Sleep Med 2017;13:235-43. [PMID: 27855741 DOI: 10.5664/jcsm.6454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
52 Flores Á, Herry C, Maldonado R, Berrendero F. Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations. Int J Neuropsychopharmacol 2017;20:654-9. [PMID: 28453642 DOI: 10.1093/ijnp/pyx029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
53 Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003;23:3555-60. [PMID: 12716965 [PMID: 12716965 DOI: 10.1523/jneurosci.23-08-03555.2003] [Cited by in Crossref: 188] [Article Influence: 9.9] [Reference Citation Analysis]
54 Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 2007;28:1286-95. [PMID: 16870307 DOI: 10.1016/j.neurobiolaging.2006.05.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
55 Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
56 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
57 Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, Okun M, Hohjoh H, Miki T, Hsu S, Leffell M, Grumet F, Fernandez-Vina M, Honda M, Risch N. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-99. [PMID: 11179016 DOI: 10.1086/318799] [Cited by in Crossref: 397] [Cited by in F6Publishing: 307] [Article Influence: 18.9] [Reference Citation Analysis]
58 Vyse TJ. Narcolepsy and the T-cell receptor. Nat Genet 2009;41:640-1. [PMID: 19471301 DOI: 10.1038/ng0609-640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
59 Sagawa Y, Sato M, Sakai N, Chikahisa S, Chiba S, Maruyama T, Yamamoto J, Nishino S. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Neuropharmacology 2016;110:268-76. [PMID: 27474349 DOI: 10.1016/j.neuropharm.2016.07.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
60 Fadel J, Burk JA. Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention. Brain Res 2010;1314:112-23. [PMID: 19699722 DOI: 10.1016/j.brainres.2009.08.046] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
61 Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008;100:2265-81. [PMID: 18667550 DOI: 10.1152/jn.01388.2007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
62 Saper CB. Hypothalamus. The Human Nervous System. Elsevier; 2004. pp. 513-50. [DOI: 10.1016/b978-012547626-3/50018-1] [Cited by in Crossref: 15] [Article Influence: 0.8] [Reference Citation Analysis]
63 Kawashima M, Lin L, Tanaka S, Jennum P, Knudsen S, Nevsimalova S, Plazzi G, Mignot E. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010;33:869-74. [PMID: 20614846 DOI: 10.1093/sleep/33.7.869] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 7.4] [Reference Citation Analysis]
64 Chng SC, Ho L, Tian J, Reversade B. ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 2013;27:672-80. [PMID: 24316148 DOI: 10.1016/j.devcel.2013.11.002] [Cited by in Crossref: 237] [Cited by in F6Publishing: 229] [Article Influence: 26.3] [Reference Citation Analysis]
65 Urade Y. Neurobiological Basis of Hypersomnia. Sleep Medicine Clinics 2017;12:265-77. [DOI: 10.1016/j.jsmc.2017.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
66 Sun Y, Tisdale RK, Kilduff TS. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases. Front Neurol Neurosci 2021;45:22-37. [PMID: 34052813 DOI: 10.1159/000514963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
67 Stettner GM, Kubin L. Antagonism of orexin receptors in the posterior hypothalamus reduces hypoglossal and cardiorespiratory excitation from the perifornical hypothalamus. J Appl Physiol (1985) 2013;114:119-30. [PMID: 23104701 DOI: 10.1152/japplphysiol.00965.2012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bårdsen K, Brede C, Kvivik I, Kvaløy JT, Jonsdottir K, Tjensvoll AB, Ruoff P, Omdal R. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren's syndrome. J Neuroinflammation 2019;16:102. [PMID: 31101054 DOI: 10.1186/s12974-019-1502-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
69 Guerreiro S, Florence C, Rousseau E, Hamadat S, Hirsch EC, Michel PP. The Sleep-Modulating Peptide Orexin-B Protects Midbrain Dopamine Neurons from Degeneration, Alone or in Cooperation with Nicotine. Mol Pharmacol 2015;87:525-32. [DOI: 10.1124/mol.114.095703] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
70 Baumann CR, Clark EL, Pedersen NP, Hecht JL, Scammell TE. Do enteric neurons make hypocretin? Regul Pept 2008;147:1-3. [PMID: 18191238 DOI: 10.1016/j.regpep.2007.11.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
71 Wise MS. Narcolepsy and other disorders of excessive sleepiness. Medical Clinics of North America 2004;88:597-610. [DOI: 10.1016/j.mcna.2004.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
72 Boss C. Orexin receptor antagonists--a patent review (2010 to August 2014). Expert Opin Ther Pat 2014;24:1367-81. [PMID: 25407283 DOI: 10.1517/13543776.2014.978859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
73 Kumar A, Chanana P, Choudhary S. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs. Pharmacological Reports 2016;68:231-42. [DOI: 10.1016/j.pharep.2015.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
74 Wang J, Xu Z, Fang H, Duhart HM, Patterson TA, Ali SF. Gene expression profiling of MPP+-treated MN9D cells: A mechanism of toxicity study. NeuroToxicology 2007;28:979-87. [DOI: 10.1016/j.neuro.2007.02.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
75 Faesel N, Kolodziejczyk MH, Koch M, Fendt M. Orexin deficiency affects sociability and the acquisition, expression, and extinction of conditioned social fear. Brain Res 2021;1751:147199. [PMID: 33160959 DOI: 10.1016/j.brainres.2020.147199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J Neurosci 2011;31:6305-10. [PMID: 21525270 DOI: 10.1523/JNEUROSCI.0365-11.2011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
77 Zhang S, Blache D, Vercoe PE, Adam CL, Blackberry MA, Findlay PA, Eidne KA, Martin GB. Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regulatory Peptides 2005;124:81-7. [DOI: 10.1016/j.regpep.2004.07.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
78 Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, Bell JI, Strominger JL, Jones EY, Fugger L. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 2004;101:1999-2004. [PMID: 14769912 DOI: 10.1073/pnas.0308458100] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
79 Krolewski DM, Medina A, Kerman IA, Bernard R, Burke S, Thompson RC, Bunney WE Jr, Schatzberg AF, Myers RM, Akil H, Jones EG, Watson SJ. Expression patterns of corticotropin-releasing factor, arginine vasopressin, histidine decarboxylase, melanin-concentrating hormone, and orexin genes in the human hypothalamus. J Comp Neurol 2010;518:4591-611. [PMID: 20886624 DOI: 10.1002/cne.22480] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
80 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Hassani OK, Krause MR, Mainville L, Cordova CA, Jones BE. Orexin Neurons Respond Differentially to Auditory Cues Associated with Appetitive versus Aversive Outcomes. J Neurosci 2016;36:1747-57. [PMID: 26843654 DOI: 10.1523/JNEUROSCI.3903-15.2016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
82 Mori T, Uzawa N, Iwase Y, Masukawa D, Rahmadi M, Hirayama S, Hokazono M, Higashiyama K, Shioda S, Suzuki T. Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT. Psychopharmacology 2016;233:2343-53. [DOI: 10.1007/s00213-016-4282-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
83 Ballotta D, Talami F, Pizza F, Vaudano AE, Benuzzi F, Plazzi G, Meletti S. Hypothalamus and amygdala functional connectivity at rest in narcolepsy type 1. Neuroimage Clin 2021;31:102748. [PMID: 34252875 DOI: 10.1016/j.nicl.2021.102748] [Reference Citation Analysis]
84 Katsuki H, Akaike A. Quinolinic acid toxicity on orexin neurons blocked by gamma aminobutyric acid type A receptor stimulation: . NeuroReport 2005;16:1157-61. [DOI: 10.1097/00001756-200508010-00005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
85 Picchioni D. Using magnetic resonance spectroscopy in narcolepsy to study the limbic mechanisms of cataplexy. Sleep 2009;32:581-2. [PMID: 19480221 DOI: 10.1093/sleep/32.5.581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Ferreira JGP, Bittencourt JC, Adamantidis A. Melanin-concentrating hormone and sleep. Current Opinion in Neurobiology 2017;44:152-8. [DOI: 10.1016/j.conb.2017.04.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
87 Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J, Hargreaves R, Goadsby PJ. Evidence for orexinergic mechanisms in migraine. Neurobiology of Disease 2015;74:137-43. [DOI: 10.1016/j.nbd.2014.10.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
88 Alexopoulos H, Dalakas MC. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Review of Clinical Immunology 2014;9:1043-53. [DOI: 10.1586/1744666x.2013.845527] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
89 Dong XS, Ma SF, Cao CW, Li J, An P, Zhao L, Liu NY, Yan H, Hu QT, Mignot E, Strohl KP, Gao ZC, Zeng C, Han F. Hypocretin (orexin) neuropeptide precursor gene, HCRT, polymorphisms in early-onset narcolepsy with cataplexy. Sleep Med 2013;14:482-7. [PMID: 23643651 DOI: 10.1016/j.sleep.2013.01.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
90 Dale NC, Hoyer D, Jacobson LH, Pfleger KDG, Johnstone EKM. Orexin Signaling: A Complex, Multifaceted Process. Front Cell Neurosci 2022;16:812359. [DOI: 10.3389/fncel.2022.812359] [Reference Citation Analysis]
91 Schöne C, Apergis-Schoute J, Sakurai T, Adamantidis A, Burdakov D. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 2014;7:697-704. [PMID: 24767990 DOI: 10.1016/j.celrep.2014.03.055] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
92 Jacobson LH, Chen S, Mir S, Hoyer D. Orexin OX2 Receptor Antagonists as Sleep Aids. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 105-36. [DOI: 10.1007/7854_2016_47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
93 Aizawa R, Sunahara H, Kume K, Tsuchiya S, Adachi H, Kanbayashi T, Shimizu T. Status of narcolepsy-related information available on the Internet in Japan and its effective use. Sleep and Biological Rhythms 2008;6:201-7. [DOI: 10.1111/j.1479-8425.2008.00362.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
94 Saletu M, Anderer P, Saletu-Zyhlarz GM, Mandl M, Saletu B, Zeitlhofer J. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). Sleep Med 2009;10:850-8. [PMID: 19342295 DOI: 10.1016/j.sleep.2008.12.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
95 Moghadam KK, Pizza F, La Morgia C, Franceschini C, Tonon C, Lodi R, Barboni P, Seri M, Ferrari S, Liguori R, Donadio V, Parchi P, Cornelio F, Inzitari D, Mignarri A, Capocchi G, Dotti MT, Winkelmann J, Lin L, Mignot E, Carelli V, Plazzi G. Narcolepsy is a common phenotype in HSAN IE and ADCA-DN. Brain 2014;137:1643-55. [DOI: 10.1093/brain/awu069] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
96 Chokroverty S, Avidan AY. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2012. pp. 1634-702. [DOI: 10.1016/b978-1-4377-0434-1.00093-1] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
97 Bayard S, Plazzi G, Poli F, Serra L, Ferri R, Dauvilliers Y. Olfactory dysfunction in narcolepsy with cataplexy. Sleep Medicine 2010;11:876-81. [DOI: 10.1016/j.sleep.2010.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
98 Taheri S. The Immune Basis of Narcolepsy. Sleep Medicine Clinics 2017;12:279-87. [DOI: 10.1016/j.jsmc.2017.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
99 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
100 Ma S, Hangya B, Leonard CS, Wisden W, Gundlach AL. Dual-transmitter systems regulating arousal, attention, learning and memory. Neurosci Biobehav Rev 2018;85:21-33. [PMID: 28757457 DOI: 10.1016/j.neubiorev.2017.07.009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
101 Michinaga S, Hisatsune A, Isohama Y, Katsuki H. An anti-Parkinson drug ropinirole depletes orexin from rat hypothalamic slice culture. Neuroscience Research 2010;68:315-21. [DOI: 10.1016/j.neures.2010.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
102 Schinkelshoek MS, Fronczek R, Kooy-Winkelaar EMC, Petersen J, Reid HH, van der Heide A, Drijfhout JW, Rossjohn J, Lammers GJ, Koning F. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. J Neuroimmunol 2019;332:167-75. [PMID: 31048269 DOI: 10.1016/j.jneuroim.2019.04.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
103 Lefter R, Cojocariu RO, Ciobica A, Balmus I, Mavroudis I, Kis A. Interactions between Sleep and Emotions in Humans and Animal Models. Medicina 2022;58:274. [DOI: 10.3390/medicina58020274] [Reference Citation Analysis]
104 Berteotti C, Lo Martire V, Alvente S, Bastianini S, Matteoli G, Silvani A, Zoccoli G. Effect of ambient temperature on sleep breathing phenotype in mice: the role of orexins. J Exp Biol 2020;223:jeb219485. [PMID: 32457059 DOI: 10.1242/jeb.219485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
105 Wheeler DS, Wan S, Miller A, Angeli N, Adileh B, Hu W, Holland PC. Role of lateral hypothalamus in two aspects of attention in associative learning. Eur J Neurosci 2014;40:2359-77. [PMID: 24750426 DOI: 10.1111/ejn.12592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
106 Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015;47:44-57. [PMID: 25452148 DOI: 10.1016/j.bbi.2014.11.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
107 Latifi B, Adamantidis A, Bassetti C, Schmidt MH. Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Front Neurol 2018;9:790. [PMID: 30344503 DOI: 10.3389/fneur.2018.00790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
108 García-garcía B, Reinoso-suárez F, Rodrigo-angulo ML. Hypothalamic Hypocretinergic/Orexinergic Neurons Projecting to the Oral Pontine Rapid Eye Movement Sleep Inducing Site in the Cat: Orexinergic Projection to Rem Induction Site. Anat Rec 2013;296:815-21. [DOI: 10.1002/ar.22690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
109 Leonard CS, Ishibashi M. Orexin Receptor Functions in the Ascending Arousal System. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 67-80. [DOI: 10.1007/978-3-319-23078-8_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 Galibert F, André C. Le génome du chien : un modèle alternatif pour l’analyse fonctionnelle des gènes de mammifères. Bulletin de l'Académie Nationale de Médecine 2002;186:1489-502. [DOI: 10.1016/s0001-4079(19)34147-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
111 Crittenden F, Thomas HR, Parant JM, Falany CN. Activity Suppression Behavior Phenotype in SULT4A1 Frameshift Mutant Zebrafish. Drug Metab Dispos 2015;43:1037-44. [PMID: 25934576 DOI: 10.1124/dmd.115.064485] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
112 Sargin D. The role of the orexin system in stress response. Neuropharmacology 2019;154:68-78. [PMID: 30266600 DOI: 10.1016/j.neuropharm.2018.09.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
113 Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 2013;14:472-87. [DOI: 10.1038/nrn3526] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
114 Govindaiah G, Cox CL. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 2006;51:414-25. [PMID: 16713607 DOI: 10.1016/j.neuropharm.2006.03.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
115 Silvani A, Grimaldi D, Barletta G, Bastianini S, Vandi S, Pierangeli G, Plazzi G, Cortelli P. Cardiovascular variability as a function of sleep-wake behaviour in narcolepsy with cataplexy. J Sleep Res 2013;22:178-84. [DOI: 10.1111/jsr.12007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
116 Poli F, Overeem S, Lammers GJ, Plazzi G, Lecendreux M, Bassetti CL, Dauvilliers Y, Keene D, Khatami R, Li Y, Mayer G, Nohynek H, Pahud B, Paiva T, Partinen M, Scammell TE, Shimabukuro T, Sturkenboom M, van Dinther K, Wiznitzer M, Bonhoeffer J. Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation. Vaccine 2013;31:994-1007. [DOI: 10.1016/j.vaccine.2012.12.014] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
117 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Del Cid-Pellitero E, Garzón M. Medial prefrontal cortex receives input from dorsal raphe nucleus neurons targeted by hypocretin1/orexinA-containing axons. Neuroscience 2011;172:30-43. [PMID: 21036204 DOI: 10.1016/j.neuroscience.2010.10.058] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
119 Petersén A, Björkqvist M. Hypothalamic-endocrine aspects in Huntington's disease. Eur J Neurosci 2006;24:961-7. [PMID: 16925587 DOI: 10.1111/j.1460-9568.2006.04985.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 7.2] [Reference Citation Analysis]
120 Dauvilliers Y, Rompré S, Gagnon JF, Vendette M, Petit D, Montplaisir J. REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep 2007;30:844-9. [PMID: 17682654 DOI: 10.1093/sleep/30.7.844] [Cited by in Crossref: 120] [Cited by in F6Publishing: 92] [Article Influence: 8.0] [Reference Citation Analysis]
121 Ollila HM, Ravel JM, Han F, Faraco J, Lin L, Zheng X, Plazzi G, Dauvilliers Y, Pizza F, Hong SC, Jennum P, Knudsen S, Kornum BR, Dong XS, Yan H, Hong H, Coquillard C, Mahlios J, Jolanki O, Einen M, Arnulf I, Högl B, Frauscher B, Crowe C, Partinen M, Huang YS, Bourgin P, Vaarala O, Désautels A, Montplaisir J, Mack SJ, Mindrinos M, Fernandez-Vina M, Mignot E. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet 2015;96:136-46. [PMID: 25574827 DOI: 10.1016/j.ajhg.2014.12.010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 12.9] [Reference Citation Analysis]
122 van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 2004;42:635-52. [PMID: 15157424 DOI: 10.1016/s0896-6273(04)00251-x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 86] [Article Influence: 8.6] [Reference Citation Analysis]
123 Scrima L. Dreaming Epiphenomena of Narcolepsy. Sleep Medicine Clinics 2010;5:261-75. [DOI: 10.1016/j.jsmc.2010.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Kishida M, Ishige K, Horibe T, Tada N, Koibuchi N, Shoda J, Kita K, Kawakami K. Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy. Oncol Lett 2012;3:525-9. [PMID: 22740944 DOI: 10.3892/ol.2011.528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
125 Zeitzer JM, Joyce DS, McBean A, Quevedo YL, Hernandez B, Holty JE. Effect of Suvorexant vs Placebo on Total Daytime Sleep Hours in Shift Workers: A Randomized Clinical Trial. JAMA Netw Open 2020;3:e206614. [PMID: 32484552 DOI: 10.1001/jamanetworkopen.2020.6614] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
126 Morales A, Bonnet C, Bourgoin N, Touvier T, Nadam J, Laglaine A, Navarro F, Moulin C, Georges B, Pequignot JM, Bezin L. Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 2006;1109:164-75. [PMID: 16904080 DOI: 10.1016/j.brainres.2006.06.075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
127 Wollmann G, Acuna-goycolea C, van den Pol AN. Direct Excitation of Hypocretin/Orexin Cells by Extracellular ATP at P2X Receptors. Journal of Neurophysiology 2005;94:2195-206. [DOI: 10.1152/jn.00035.2005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
128 Miyagawa T, Tanaka S, Shimada M, Sakai N, Tanida K, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kanbayashi T, Imanishi A, Ikegami A, Kamei Y, Hida A, Wada Y, Miyamoto M, Takami M, Kondo H, Tamura Y, Taniyama Y, Omata N, Mizuno T, Moriya S, Furuya H, Kato M, Kato K, Ishigooka J, Tsuruta K, Chiba S, Yamada N, Okawa M, Hirata K, Kuroda K, Kume K, Uchimura N, Kitada M, Kodama T, Inoue Y, Nishino S, Mishima K, Tokunaga K, Honda M. A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia. NPJ Genom Med 2022;7:29. [PMID: 35414074 DOI: 10.1038/s41525-022-00298-w] [Reference Citation Analysis]
129 Dauvilliers Y, Arnulf I. Narcolepsie avec cataplexie. Revue Neurologique 2008;164:634-45. [DOI: 10.1016/j.neurol.2007.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
130 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
131 Dorris L, Scott N, Zuberi S, Gibson N, Espie C. Sleep problems in children with neurological disorders. Developmental Neurorehabilitation 2009;11:95-114. [DOI: 10.1080/17518420701860149] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
132 Boehmer L, Wu M, John J, Siegel J. Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Experimental Neurology 2004;188:292-9. [DOI: 10.1016/j.expneurol.2004.04.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
133 Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-63. [DOI: 10.1038/nature04284] [Cited by in Crossref: 1577] [Cited by in F6Publishing: 1306] [Article Influence: 92.8] [Reference Citation Analysis]
134 Hara J, Yanagisawa M, Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neuroscience Letters 2005;380:239-42. [DOI: 10.1016/j.neulet.2005.01.046] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 7.3] [Reference Citation Analysis]
135 Zaharna M, Dimitriu A, Guilleminault C. Expert opinion on pharmacotherapy of narcolepsy. Expert Opin Pharmacother 2010;11:1633-45. [PMID: 20426704 DOI: 10.1517/14656566.2010.484021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
136 Gerashchenko D, Shiromani PJ. Effects of inflammation produced by chronic lipopolysaccharide administration on the survival of hypocretin neurons and sleep. Brain Research 2004;1019:162-9. [DOI: 10.1016/j.brainres.2004.06.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
137 Han F. Narcolepsy, orexins and respiratory regulation: Respiratory regulation in narcolepsy. Sleep and Biological Rhythms 2011;9:44-51. [DOI: 10.1111/j.1479-8425.2010.00467.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
138 Chokroverty S. Sleep and Its Disorders. Neurology in Clinical Practice. Elsevier; 2008. pp. 1947-2009. [DOI: 10.1016/b978-0-7506-7525-3.50110-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
139 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Reference Citation Analysis]
140 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
141 Chen YH, Huang YS, Chien WH, Chen CH. Association analysis of the major histocompatibility complex, class II, DQ β1 gene, HLA-DQB1, with narcolepsy in Han Chinese patients from Taiwan. Sleep Med 2013;14:1393-7. [PMID: 24157097 DOI: 10.1016/j.sleep.2013.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
142 Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002;22:2862-72. [PMID: 11923451 DOI: 20026234] [Cited by in Crossref: 184] [Article Influence: 9.2] [Reference Citation Analysis]
143 Gerashchenko D, Blanco-Centurion C, Greco MA, Shiromani PJ. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience 2003;116:223-35. [PMID: 12535955 DOI: 10.1016/s0306-4522(02)00575-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
144 Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
145 Dijk D, Lockley SW. Invited Review: Integration of human sleep-wake regulation and circadian rhythmicity. Journal of Applied Physiology 2002;92:852-62. [DOI: 10.1152/japplphysiol.00924.2001] [Cited by in Crossref: 232] [Cited by in F6Publishing: 185] [Article Influence: 11.6] [Reference Citation Analysis]
146 Shimada M, Miyagawa T, Kodama T, Toyoda H, Tokunaga K, Honda M. Metabolome analysis using cerebrospinal fluid from narcolepsy type 1 patients. Sleep 2020;43:zsaa095. [PMID: 32412602 DOI: 10.1093/sleep/zsaa095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35. [PMID: 19723027 DOI: 10.1111/j.1748-1716.2009.02036.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
148 James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
149 Lopez R, Dauvilliers Y. Pharmacotherapy options for cataplexy. Expert Opin Pharmacother 2013;14:895-903. [PMID: 23521426 DOI: 10.1517/14656566.2013.783021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
150 Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, Sagvolden T. Response variability in Attention-Deficit/Hyperactivity Disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006;2:30. [PMID: 16925830 DOI: 10.1186/1744-9081-2-30] [Cited by in Crossref: 139] [Cited by in F6Publishing: 143] [Article Influence: 8.7] [Reference Citation Analysis]
151 Bernard-Valnet R, Frieser D, Nguyen XH, Khajavi L, Quériault C, Arthaud S, Melzi S, Fusade-Boyer M, Masson F, Zytnicki M, Saoudi A, Dauvilliers Y, Peyron C, Bauer J, Liblau RS. Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy. Brain 2022:awab455. [PMID: 35552381 DOI: 10.1093/brain/awab455] [Reference Citation Analysis]
152 Jacobson LH, Callander GE, Hoyer D. Suvorexant for the treatment of insomnia. Expert Rev Clin Pharmacol 2014;7:711-30. [PMID: 25318834 DOI: 10.1586/17512433.2014.966813] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
153 Posar A, Pizza F, Parmeggiani A, Plazzi G. Neuropsychological findings in childhood narcolepsy. J Child Neurol 2014;29:1370-6. [PMID: 24293310 DOI: 10.1177/0883073813508315] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
154 Voisin T, Firar AE, Avondo V, Laburthe M. Orexin-induced apoptosis: the key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 2006;147:4977-84. [PMID: 16857748 DOI: 10.1210/en.2006-0201] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
155 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Chen A, Singh C, Oikonomou G, Prober DA. Genetic Analysis of Histamine Signaling in Larval Zebrafish Sleep. eNeuro 2017;4:ENEURO. [PMID: 28275716 DOI: 10.1523/ENEURO.0286-16.2017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
157 Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-semenescu S, Jaussent I, Dauvilliers Y. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology 2016;88:93-100. [DOI: 10.1212/wnl.0000000000003432] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
158 Freeman LR, Aston-Jones G. Activation of medial hypothalamic orexin neurons during a Go/No-Go task. Brain Res 2020;1731:145928. [PMID: 30176242 DOI: 10.1016/j.brainres.2018.08.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
159 Harro J, Laas K, Eensoo D, Kurrikoff T, Sakala K, Vaht M, Parik J, Mäestu J, Veidebaum T. Orexin/hypocretin receptor gene (HCRTR1) variation is associated with aggressive behaviour. Neuropharmacology 2019;156:107527. [DOI: 10.1016/j.neuropharm.2019.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
160 Pfaff D, Westberg L, Kow LM. Generalized arousal of mammalian central nervous system. J Comp Neurol 2005;493:86-91. [PMID: 16254992 DOI: 10.1002/cne.20720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
161 Mckenna D, Peever J. Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder: Degeneration of REM sleep circuitry underlies RBD. Mov Disord 2017;32:636-44. [DOI: 10.1002/mds.27003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
162 Schreyer S, Büttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience 2009;164:629-40. [PMID: 19703526 DOI: 10.1016/j.neuroscience.2009.08.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
163 Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 2003;465:593-603. [PMID: 12975818 DOI: 10.1002/cne.10860] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 8.7] [Reference Citation Analysis]
164 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
165 Siegel JM. Rapid Eye Movement Sleep. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 78-95.e6. [DOI: 10.1016/b978-0-323-24288-2.00008-8] [Cited by in Crossref: 13] [Article Influence: 2.6] [Reference Citation Analysis]
166 Schmidt FM, Brügel M, Kratzsch J, Strauß M, Sander C, Baum P, Thiery J, Hegerl U, Schönknecht P. Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls. Neuroscience Letters 2010;483:20-2. [DOI: 10.1016/j.neulet.2010.07.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
167 Smith O. Biomedicine. Nota bene: sleep, eat, and be merry. Science 2000;289:1706. [PMID: 11001739 DOI: 10.1126/science.289.5485.1706] [Reference Citation Analysis]
168 Nishino S, Mignot E. Article reviewed: Plasma orexin-A is lower in patients with narcolepsy. Sleep Medicine 2002;3:377-8. [DOI: 10.1016/s1389-9457(02)00078-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
169 Abad VC, Guilleminault C. Emerging drugs for narcolepsy. Expert Opinion on Emerging Drugs 2005;9:281-91. [DOI: 10.1517/14728214.9.2.281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
170 Bockaert J, Claeysen S, Bécamel C, Sylvie P, Dumuis A. G Protein-Coupled Receptors: Dominant Players in Cell–Cell Communication. A Survey of Cell Biology. Elsevier; 2002. pp. 63-136e. [DOI: 10.1016/s0074-7696(01)12004-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
171 Burdakov D, Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005;9:795-803. [PMID: 16364191 DOI: 10.1111/j.1582-4934.2005.tb00380.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
172 Naganuma F, Bandaru SS, Absi G, Mahoney CE, Scammell TE, Vetrivelan R. Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy. Neurobiol Dis 2018;120:12-20. [PMID: 30149182 DOI: 10.1016/j.nbd.2018.08.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
173 Quaedackers L, Droogleever Fortuyn H, Van Gilst M, Lappenschaar M, Overeem S. Dissociative Symptoms are Highly Prevalent in Adults with Narcolepsy Type 1. Behav Sleep Med 2021;:1-11. [PMID: 33594925 DOI: 10.1080/15402002.2021.1888729] [Reference Citation Analysis]
174 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
175 Barateau L, Chenini S, Evangelista E, Jaussent I, Lopez R, Dauvilliers Y. Clinical autonomic dysfunction in narcolepsy type 1. Sleep 2019;42:zsz187. [DOI: 10.1093/sleep/zsz187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
176 Thompson MD, Burnham WM, Cole DE. The G protein-coupled receptors: pharmacogenetics and disease. Crit Rev Clin Lab Sci 2005;42:311-92. [PMID: 16281738 DOI: 10.1080/10408360591001895] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.0] [Reference Citation Analysis]
177 Arias-Carrión O, Murillo-Rodriguez E, Xu M, Blanco-Centurion C, Drucker-Colín R, Shiromani PJ. Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep 2004;27:1465-70. [PMID: 15683135 DOI: 10.1093/sleep/27.8.1465] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
178 Hoever P, Hay J, Rad M, Cavallaro M, van Gerven JM, Dingemanse J. Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Almorexant, an Orexin Receptor Antagonist, in Healthy Elderly Subjects. Journal of Clinical Psychopharmacology 2013;33:363-70. [DOI: 10.1097/jcp.0b013e31828f5a7a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
179 Buskova J, Klaschka J, Sonka K, Nevsimalova S. Olfactory dysfunction in narcolepsy with and without cataplexy. Sleep Med 2010;11:558-61. [PMID: 20513636 DOI: 10.1016/j.sleep.2010.01.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
180 López M, Nogueiras R, Tena-Sempere M, Diéguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf) 2010;198:325-34. [PMID: 19769635 DOI: 10.1111/j.1748-1716.2009.02042.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
181 Nishino S, Deguzman C, Yamadera W, Chiba S, Kanbayashi T. Neurochemistry and Biomarkers of Narcolepsy and Other Primary and Secondary Hypersomnias. Sleep Medicine Clinics 2012;7:233-48. [DOI: 10.1016/j.jsmc.2012.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
182 Nishino S, Yoshida Y. History and perspectives of hypocretin/orexin research in sleep medicine. Sleep and Biological Rhythms 2003;1:43-54. [DOI: 10.1046/j.1446-9235.2003.00001.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
183 Kummer M, Neidert SJ, Jöhren O, Dominiak P. Orexin (hypocretin) gene expression in rat ependymal cells: . Neuroreport 2001;12:2117-20. [DOI: 10.1097/00001756-200107200-00015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
184 Dauvilliers Y, Tafti M, Landolt HP. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation. Sleep Medicine Reviews 2015;22:47-53. [DOI: 10.1016/j.smrv.2014.10.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
185 Burgess CR, Oishi Y, Mochizuki T, Peever JH, Scammell TE. Amygdala lesions reduce cataplexy in orexin knock-out mice. J Neurosci 2013;33:9734-42. [PMID: 23739970 DOI: 10.1523/JNEUROSCI.5632-12.2013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
186 Obukuro K, Takigawa M, Hisatsune A, Isohama Y, Katsuki H. Quinolinate induces selective loss of melanin-concentrating hormone neurons, rather than orexin neurons, in the hypothalamus of mice and young rats. Neuroscience 2010;170:298-307. [DOI: 10.1016/j.neuroscience.2010.06.081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
187 Kothare SV, Kaleyias J. The clinical and laboratory assessment of the sleepy child. Semin Pediatr Neurol 2008;15:61-9. [PMID: 18555192 DOI: 10.1016/j.spen.2008.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
188 Steininger TL, Kilduff TS, Behan M, Benca RM, Landry CF. Comparison of hypocretin/orexin and melanin-concentrating hormone neurons and axonal projections in the embryonic and postnatal rat brain. Journal of Chemical Neuroanatomy 2004;27:165-81. [DOI: 10.1016/j.jchemneu.2004.02.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 2.5] [Reference Citation Analysis]
189 Tanaka S, Toyoda H, Honda Y, Seki Y, Sakurai T, Honda K, Kodama T. Hypocretin/orexin prevents recovery from sickness. Biomed Rep 2015;3:648-50. [PMID: 26405539 DOI: 10.3892/br.2015.491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
190 Konadhode RR, Pelluru D, Shiromani PJ. Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep. Front Syst Neurosci 2014;8:244. [PMID: 25620917 DOI: 10.3389/fnsys.2014.00244] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
191 Wells A, Kopp N, Xu X, O'Brien DR, Yang W, Nehorai A, Adair-Kirk TL, Kopan R, Dougherty JD. The anatomical distribution of genetic associations. Nucleic Acids Res 2015;43:10804-20. [PMID: 26586807 DOI: 10.1093/nar/gkv1262] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
192 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
193 Miura T, Maruyama K, Shimakura S, Kaiya H, Uchiyama M, Kangawa K, Shioda S, Matsuda K. Regulation of food intake in the goldfish by interaction between ghrelin and orexin. Peptides 2007;28:1207-13. [DOI: 10.1016/j.peptides.2007.03.023] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 6.0] [Reference Citation Analysis]
194 Poryazova R, Schnepf B, Werth E, Khatami R, Dydak U, Meier D, Boesiger P, Bassetti CL. Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy. Sleep 2009;32:607-13. [PMID: 19480227 DOI: 10.1093/sleep/32.5.607] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
195 Fu LY, Acuna-Goycolea C, van den Pol AN. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 2004;24:8741-51. [PMID: 15470140 DOI: 10.1523/JNEUROSCI.2268-04.2004] [Cited by in Crossref: 112] [Cited by in F6Publishing: 71] [Article Influence: 6.6] [Reference Citation Analysis]
196 Nishino S, Sakurai E, Nevsimalova S, Yoshida Y, Watanabe T, Yanai K, Mignot E. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 2009;32:175-80. [PMID: 19238804 DOI: 10.1093/sleep/32.2.175] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 7.2] [Reference Citation Analysis]
197 Pintwala S, Peever J. Circuit mechanisms of sleepiness and cataplexy in narcolepsy. Current Opinion in Neurobiology 2017;44:50-8. [DOI: 10.1016/j.conb.2017.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
198 Shan L, Bao AM, Swaab DF. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci 2015;38:167-77. [PMID: 25575625 DOI: 10.1016/j.tins.2014.12.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
199 Williams VM, Bhagwandin A, Swiegers J, Bertelsen MF, Hård T, Thannickal TC, Siegel JM, Sherwood CC, Manger PR. Nuclear organization of orexinergic neurons in the hypothalamus of a lar gibbon and a chimpanzee. Anat Rec (Hoboken) 2021. [PMID: 34535040 DOI: 10.1002/ar.24775] [Reference Citation Analysis]
200 Dahmen N, Kasten M, Wieczorek S, Gencik M, Epplen JT, Ullrich B. Increased frequency of migraine in narcoleptic patients: a confirmatory study. Cephalalgia 2003;23:14-9. [PMID: 12534574 DOI: 10.1046/j.1468-2982.2003.00343.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
201 Pedrazzoli M, D'almeida V, Martins PJ, Machado RB, Ling L, Nishino S, Tufik S, Mignot E. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Research 2004;995:1-6. [DOI: 10.1016/j.brainres.2003.09.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
202 Logan Black J. Narcolepsy: A review of evidence for autoimmune diathesis. International Review of Psychiatry 2009;17:461-9. [DOI: 10.1080/02646830500381492] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
203 Xie X, Wisor JP, Hara J, Crowder TL, LeWinter R, Khroyan TV, Yamanaka A, Diano S, Horvath TL, Sakurai T, Toll L, Kilduff TS. Hypocretin/orexin and nociceptin/orphanin FQ coordinately regulate analgesia in a mouse model of stress-induced analgesia. J Clin Invest 2008;118:2471-81. [PMID: 18551194 DOI: 10.1172/JCI35115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 0.6] [Reference Citation Analysis]
204 Lindström M, Schinkelshoek M, Tienari PJ, Kukkonen JP, Renkonen R, Fronczek R, Lammers GJ, Itkonen O. Orexin-A measurement in narcolepsy: A stability study and a comparison of LC-MS/MS and immunoassays. Clin Biochem 2021;90:34-9. [PMID: 33539807 DOI: 10.1016/j.clinbiochem.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Chicurel M. The sandman's secrets. Nature 2000;407:554-6. [DOI: 10.1038/35036738] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
206 Dauvilliers Y, Carlander B, François, Touchon J, Tafti M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset: Management of Cataplexy with IVIg. Ann Neurol 2004;56:905-8. [DOI: 10.1002/ana.20339] [Cited by in Crossref: 125] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
207 Lamb F, Ploner A, Fink K, Maeurer M, Bergman P, Piehl F, Weibel D, Sparén P, Dahlström LA. No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination. PLoS One 2016;11:e0154296. [PMID: 27120092 DOI: 10.1371/journal.pone.0154296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
208 Campbell EJ, Norman A, Bonomo Y, Lawrence AJ. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial. Brain Res 2020;1728:146597. [PMID: 31837287 DOI: 10.1016/j.brainres.2019.146597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
209 Wang W, Pan Y, Li Q, Wang L. Orexin: A potential role in the process of obstructive sleep apnea. Peptides 2013;42:48-54. [DOI: 10.1016/j.peptides.2013.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
210 Deats SP, Adidharma W, Lonstein JS, Yan L. Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency. Neuroscience 2014;272:252-60. [PMID: 24813431 DOI: 10.1016/j.neuroscience.2014.04.069] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
211 Sotelo MI, Tyan J, Markunas C, Sulaman BA, Horwitz L, Lee H, Morrow JG, Rothschild G, Duan B, Eban-Rothschild A. Lateral hypothalamic neuronal ensembles regulate pre-sleep nest-building behavior. Curr Biol 2022:S0960-9822(21)01740-1. [PMID: 35051354 DOI: 10.1016/j.cub.2021.12.053] [Reference Citation Analysis]
212 Akintomide GS, Rickards H. Narcolepsy: a review. Neuropsychiatr Dis Treat 2011;7:507-18. [PMID: 21931493 DOI: 10.2147/NDT.S23624] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
213 Tafti M, Franken P. Invited Review: Genetic dissection of sleep. Journal of Applied Physiology 2002;92:1339-47. [DOI: 10.1152/japplphysiol.00834.2001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
214 Mori I. The olfactory bulb: A link between environmental agents and narcolepsy. Med Hypotheses 2019;126:66-8. [PMID: 31010502 DOI: 10.1016/j.mehy.2019.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
215 Revell VL, Della Monica C, Mendis J, Hassanin H, Halter RJ, Chaplan SR, Dijk DJ. Effects of the selective orexin-2 receptor antagonist JNJ-48816274 on sleep initiated in the circadian wake maintenance zone: a randomised trial. Neuropsychopharmacology 2021. [PMID: 34628482 DOI: 10.1038/s41386-021-01175-3] [Reference Citation Analysis]
216 Arias-Carrión O, Drucker-Colín R, Murillo-Rodríguez E. Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci Lett 2006;404:93-7. [PMID: 16762505 DOI: 10.1016/j.neulet.2006.05.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
217 Margetis K, Korfias SI, Gatzonis S, Boutos N, Stranjalis G, Boviatsis E, Sakas DE. Intrathecal baclofen associated with improvement of consciousness disorders in spasticity patients. Neuromodulation 2014;17:699-704: discussion 704. [PMID: 24350688 DOI: 10.1111/ner.12147] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
218 Hong C, Byrne NJ, Zamlynny B, Tummala S, Xiao L, Shipman JM, Partridge AT, Minnick C, Breslin MJ, Rudd MT, Stachel SJ, Rada VL, Kern JC, Armacost KA, Hollingsworth SA, O'Brien JA, Hall DL, McDonald TP, Strickland C, Brooun A, Soisson SM, Hollenstein K. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nat Commun 2021;12:815. [PMID: 33547286 DOI: 10.1038/s41467-021-21087-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
219 Romigi A, Vitrani G, Lo Giudice T, Centonze D, Franco V. Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy. Drug Des Devel Ther 2018;12:2665-75. [PMID: 30214155 DOI: 10.2147/DDDT.S101145] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
220 Kirwan P, Jura M, Merkle FT. Generation and Characterization of Functional Human Hypothalamic Neurons. Curr Protoc Neurosci 2017;81:3.33.1-3.33.24. [PMID: 29064566 DOI: 10.1002/cpns.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
221 Nishino S, Ripley B, Mignot E, Benson KL, Zarcone VP. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture. Psychiatry Research 2002;110:1-7. [DOI: 10.1016/s0165-1781(02)00032-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
222 Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM. Cerebrospinal fluid hypocretin (orexin) levels are elevated by play but are not raised by exercise and its associated heart rate, blood pressure, respiration or body temperature changes. Arch Ital Biol 2011;149:492-8. [PMID: 22205595 DOI: 10.4449/aib.v149i4.1315] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
223 Hoyer D, Jacobson LH. Orexin Receptor Antagonists. Curr Sleep Medicine Rep 2017;3:342-53. [DOI: 10.1007/s40675-017-0099-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 137-56. [DOI: 10.1007/7854_2016_51] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
225 Viste R, Viken MK, Lie BA, Juvodden HT, Nordstrand SEH, Thorsby PM, Rootwelt T, Kornum BR, Knudsen-Heier S. High nocturnal sleep fragmentation is associated with low T lymphocyte P2Y11 protein levels in narcolepsy type 1. Sleep 2021:zsab062. [PMID: 33710305 DOI: 10.1093/sleep/zsab062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
226 Holland P, Goadsby PJ. The Hypothalamic Orexinergic System: Pain and Primary Headaches. Headache: The Journal of Head and Face Pain 2007;47:951-62. [DOI: 10.1111/j.1526-4610.2007.00842.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 8.5] [Reference Citation Analysis]
227 Hassani OK, Lee MG, Jones BE. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc Natl Acad Sci U S A 2009;106:2418-22. [PMID: 19188611 DOI: 10.1073/pnas.0811400106] [Cited by in Crossref: 289] [Cited by in F6Publishing: 267] [Article Influence: 22.2] [Reference Citation Analysis]
228 Zeitzer JM, Buckmaster CL, Lyons DM, Mignot E. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol 2004;557:1045-53. [PMID: 15107479 DOI: 10.1113/jphysiol.2004.061606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
229 Alam MN, Kumar S, Rai S, Methippara M, Szymusiak R, McGinty D. Role of adenosine A(1) receptor in the perifornical-lateral hypothalamic area in sleep-wake regulation in rats. Brain Res 2009;1304:96-104. [PMID: 19781535 DOI: 10.1016/j.brainres.2009.09.066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
230 Arrigoni E, Fuller PM. The Circuit, Cellular, and Synaptic Bases of Sleep-Wake Regulation. Handbook of Sleep Research. Elsevier; 2019. pp. 65-88. [DOI: 10.1016/b978-0-12-813743-7.00005-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Won C, Mahmoudi M, Qin L, Purvis T, Mathur A, Mohsenin V. The impact of gender on timeliness of narcolepsy diagnosis. J Clin Sleep Med 2014;10:89-95. [PMID: 24426826 DOI: 10.5664/jcsm.3370] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
232 Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg T, Koehl M, Uhl G, Nishino S, Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002;23:2203-11. [DOI: 10.1016/s0196-9781(02)00251-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
233 Murai Y, Akaike T. Orexins cause depolarization via nonselective cationic and K+ channels in isolated locus coeruleus neurons. Neuroscience Research 2005;51:55-65. [DOI: 10.1016/j.neures.2004.09.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
234 Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
235 Nakamachi T, Matsuda K, Maruyama K, Miura T, Uchiyama M, Funahashi H, Sakurai T, Shioda S. Regulation by orexin of feeding behaviour and locomotor activity in the goldfish. J Neuroendocrinol 2006;18:290-7. [PMID: 16503924 DOI: 10.1111/j.1365-2826.2006.01415.x] [Cited by in Crossref: 110] [Cited by in F6Publishing: 103] [Article Influence: 6.9] [Reference Citation Analysis]
236 Shiromani PJ, Peever JH. New Neuroscience Tools That Are Identifying the Sleep-Wake Circuit. Sleep 2017;40. [PMID: 28329204 DOI: 10.1093/sleep/zsx032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
237 Arnulf I. [Normal and disordered sleep]. Ann Pharm Fr 2007;65:239-50. [PMID: 17652992 DOI: 10.1016/s0003-4509(07)90042-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
238 Anastasian ZH, Ornstein E, Heyer EJ. Delayed arousal. Anesthesiol Clin 2009;27:429-50, table of contents. [PMID: 19825485 DOI: 10.1016/j.anclin.2009.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
239 Assisi L, Tafuri S, Liguori G, Paino S, Pavone LM, Staiano N, Vittoria A. Expression and role of receptor 1 for orexins in seminiferous tubules of rat testis. Cell Tissue Res 2012;348:601-7. [DOI: 10.1007/s00441-012-1394-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
240 Rotter A, Asemann R, Decker A, Kornhuber J, Biermann T. Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder. Journal of Affective Disorders 2011;131:186-92. [DOI: 10.1016/j.jad.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
241 Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 2007;27:4870-81. [PMID: 17475795 DOI: 10.1523/JNEUROSCI.0732-07.2007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
242 Liu M, Blanco-Centurion C, Konadhode RR, Luan L, Shiromani PJ. Orexin gene transfer into the amygdala suppresses both spontaneous and emotion-induced cataplexy in orexin-knockout mice. Eur J Neurosci 2016;43:681-8. [PMID: 26741960 DOI: 10.1111/ejn.13158] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
243 Sjöstrand C. Genetic aspects of cluster headache. Expert Review of Neurotherapeutics 2014;9:359-68. [DOI: 10.1586/14737175.9.3.359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
244 Yu L, Zhang XY, Chen ZP, Zhuang QX, Zhu JN, Wang JJ. Orexin excites rat inferior vestibular nuclear neurons via co-activation of OX1 and OX 2 receptors. J Neural Transm (Vienna) 2015;122:747-55. [PMID: 25371350 DOI: 10.1007/s00702-014-1330-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
245 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
246 Sharf R, Sarhan M, Dileone RJ. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry 2008;64:175-83. [PMID: 18423425 DOI: 10.1016/j.biopsych.2008.03.006] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.5] [Reference Citation Analysis]
247 Ishibashi M, Gumenchuk I, Miyazaki K, Inoue T, Ross WN, Leonard CS. Hypocretin/Orexin Peptides Alter Spike Encoding by Serotonergic Dorsal Raphe Neurons through Two Distinct Mechanisms That Increase the Late Afterhyperpolarization. J Neurosci 2016;36:10097-115. [PMID: 27683906 DOI: 10.1523/JNEUROSCI.0635-16.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
248 Truzzi GM, Cremaschi RC, Coelho FM. Human hypocretin-deficient narcolepsy - aberrant food choice due to impaired taste? Sleep Sci 2017;10:78-9. [PMID: 28966744 DOI: 10.5935/1984-0063.20170014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
249 Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
250 Furutani N, Hondo M, Tsujino N, Sakurai T. Activation of Bombesin Receptor Subtype-3 Influences Activity of Orexin Neurons by Both Direct and Indirect Pathways. J Mol Neurosci 2010;42:106-11. [DOI: 10.1007/s12031-010-9382-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
251 Flores Á, Saravia R, Maldonado R, Berrendero F. Orexins and fear: implications for the treatment of anxiety disorders. Trends in Neurosciences 2015;38:550-9. [DOI: 10.1016/j.tins.2015.06.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
252 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005;46:787-98. [PMID: 15924864 DOI: 10.1016/j.neuron.2005.04.035] [Cited by in Crossref: 579] [Cited by in F6Publishing: 545] [Article Influence: 34.1] [Reference Citation Analysis]
253 Willie JT, Lim MM, Bennett RE, Azarion AA, Schwetye KE, Brody DL. Controlled cortical impact traumatic brain injury acutely disrupts wakefulness and extracellular orexin dynamics as determined by intracerebral microdialysis in mice. J Neurotrauma 2012;29:1908-21. [PMID: 22607167 DOI: 10.1089/neu.2012.2404] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
254 Picchioni D, Hope CR, Harsh JR. A case-control study of the environmental risk factors for narcolepsy. Neuroepidemiology 2007;29:185-92. [PMID: 18043003 DOI: 10.1159/000111581] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
255 Lindberg J, Saetre P, Nishino S, Mignot E, Jazin E. Reduced expression of TAC1, PENK and SOCS2 in Hcrtr-2 mutated narcoleptic dog brain. BMC Neurosci 2007;8:34. [PMID: 17521418 DOI: 10.1186/1471-2202-8-34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
256 Barnett S, Li A. Orexin in Respiratory and Autonomic Regulation, Health and Diseases. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 345-63. [DOI: 10.1002/cphy.c190013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 Ferguson D, Wrigley S, Purcell E, Keane S, McGinn B, O'Malley S, Lynch B, Crowe C. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. [PMID: 33289477 DOI: 10.5664/jcsm.9052] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Wu MF, John J, Boehmer LN, Yau D, Nguyen GB, Siegel JM. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J Physiol 2004;554:202-15. [PMID: 14678502 DOI: 10.1113/jphysiol.2003.052134] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 4.1] [Reference Citation Analysis]
259 Schwimmer H, Stauss HM, Abboud F, Nishino S, Mignot E, Zeitzer JM. Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins. J Appl Physiol (1985) 2010;109:1053-63. [PMID: 20705949 DOI: 10.1152/japplphysiol.00516.2010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
260 Brischoux F, Mainville L, Jones BE. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 2008;510:607-30. [DOI: 10.1002/cne.21803] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
261 Siegel JM. REM Sleep. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 120-35. [DOI: 10.1016/b0-72-160797-7/50017-3] [Cited by in Crossref: 40] [Article Influence: 2.4] [Reference Citation Analysis]
262 Tang J, Chen J, Ramanjaneya M, Punn A, Conner AC, Randeva HS. The signalling profile of recombinant human orexin-2 receptor. Cellular Signalling 2008;20:1651-61. [DOI: 10.1016/j.cellsig.2008.05.010] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 5.5] [Reference Citation Analysis]
263 Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001;98:9965-70. [PMID: 11493714 DOI: 10.1073/pnas.181330998] [Cited by in Crossref: 376] [Cited by in F6Publishing: 336] [Article Influence: 17.9] [Reference Citation Analysis]
264 Waleh N, Apte-deshpande A, Terao A, Ding J, Kilduff T. Modulation of the promoter region of prepro-hypocretin by α-interferon. Gene 2001;262:123-8. [DOI: 10.1016/s0378-1119(00)00544-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
265 Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding C, Lecomte J, Schwartz J. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology 2013;12:1068-75. [DOI: 10.1016/s1474-4422(13)70225-4] [Cited by in Crossref: 207] [Cited by in F6Publishing: 62] [Article Influence: 23.0] [Reference Citation Analysis]
266 Nevšimalová S. Chapter 26 Excessive daytime sleepiness. Advances in Clinical Neurophysiology, XV International Congress of Clinical Neurophysiology. Elsevier; 2002. pp. 175-9. [DOI: 10.1016/s1567-424x(09)70446-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
267 Holland PR. Biology of Neuropeptides: Orexinergic Involvement in Primary Headache Disorders. Headache 2017;57 Suppl 2:76-88. [PMID: 28485849 DOI: 10.1111/head.13078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
268 Nishino S, Sagawa Y. The Neurochemistry of Awakening. Science of Awakening. Elsevier; 2010. pp. 229-55. [DOI: 10.1016/s0074-7742(10)93010-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
269 Crompton DE, Berkovic SF. The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures. Lancet Neurol 2009;8:370-81. [PMID: 19296920 DOI: 10.1016/S1474-4422(09)70059-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 9] [Article Influence: 5.1] [Reference Citation Analysis]
270 Cole AG, Stroke IL, Qin L, Hussain Z, Simhadri S, Brescia M, Waksmunski FS, Strohl B, Tellew JE, Williams JP, Saunders J, Appell KC, Henderson I, Webb ML. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5420-3. [DOI: 10.1016/j.bmcl.2008.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
271 Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013;23:767-73. [PMID: 23725858 DOI: 10.1016/j.conb.2013.04.013] [Cited by in Crossref: 110] [Cited by in F6Publishing: 84] [Article Influence: 12.2] [Reference Citation Analysis]
272 Hoyer D, Allen A, Jacobson LH. Hypnotics with novel modes of action. Br J Clin Pharmacol 2020;86:244-9. [PMID: 31756268 DOI: 10.1111/bcp.14180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
273 Bassetti CLA, Adamantidis A, Burdakov D, Han F, Gay S, Kallweit U, Khatami R, Koning F, Kornum BR, Lammers GJ, Liblau RS, Luppi PH, Mayer G, Pollmächer T, Sakurai T, Sallusto F, Scammell TE, Tafti M, Dauvilliers Y. Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39. [DOI: 10.1038/s41582-019-0226-9] [Cited by in Crossref: 113] [Cited by in F6Publishing: 89] [Article Influence: 37.7] [Reference Citation Analysis]
274 Bućan M, Abel T. The mouse: genetics meets behaviour. Nat Rev Genet 2002;3:114-23. [DOI: 10.1038/nrg728] [Cited by in Crossref: 117] [Cited by in F6Publishing: 114] [Article Influence: 5.9] [Reference Citation Analysis]
275 Kilduff TS. Narcolepsy: a neurodegenerative disease of the hypocretin/orexin system? Trends in Neurosciences 2000;23:512. [DOI: 10.1016/s0166-2236(00)01699-4] [Reference Citation Analysis]
276 Croizier S, Chometton S, Fellmann D, Risold PY. Characterization of a mammalian prosencephalic functional plan. Front Neuroanat 2014;8:161. [PMID: 25610375 DOI: 10.3389/fnana.2014.00161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
277 Postiglione E, Antelmi E, Pizza F, Lecendreux M, Dauvilliers Y, Plazzi G. The clinical spectrum of childhood narcolepsy. Sleep Medicine Reviews 2018;38:70-85. [DOI: 10.1016/j.smrv.2017.04.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
278 Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, Tafuri D, Salerno M, Filippi N, Nuccio F, Ruberto M, De Luca V, Cipolloni L, Cibelli G, Mollica MP, Iacono D, Nigro E, Monda M, Messina G, Messina A. Orexin System: The Key for a Healthy Life. Front Physiol 2017;8:357. [PMID: 28620314 DOI: 10.3389/fphys.2017.00357] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 13.6] [Reference Citation Analysis]
279 Silvani A, Vandi S, Pizza F, Antelmi E, Ferri R, Plazzi G. Combining information on nocturnal rapid eye movement sleep latency and atonia to facilitate diagnosis of pediatric narcolepsy type 1. Sleep 2021;44:zsaa203. [PMID: 33035342 DOI: 10.1093/sleep/zsaa203] [Reference Citation Analysis]
280 Chen W, Zeitzer JM, Mignot E. The Hypocretins and Narcolepsy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 235-54. [DOI: 10.1007/0-387-25446-3_15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
281 Demidova A, Kahl E, Fendt M. Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110517] [Reference Citation Analysis]
282 Luppi PH. [Michel Jouvet, from the discovery of paradoxical sleep and muscle atonia to the role of neuropeptides]. Biol Aujourdhui 2019;213:81-6. [PMID: 31829929 DOI: 10.1051/jbio/2019024] [Reference Citation Analysis]
283 Ahmed SS, Schur PH, Macdonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. Journal of Autoimmunity 2014;50:1-11. [DOI: 10.1016/j.jaut.2014.01.033] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 11.5] [Reference Citation Analysis]
284 Hagen J, Lyon W, Chushak Y, Tomczak M, Naik R, Stone M, Kelley-Loughnane N. Detection of orexin A neuropeptide in biological fluids using a zinc oxide field effect transistor. ACS Chem Neurosci 2013;4:444-53. [PMID: 23509980 DOI: 10.1021/cn300159e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
285 Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 2011;31:6518-26. [PMID: 21525292 DOI: 10.1523/JNEUROSCI.6506-10.2011] [Cited by in Crossref: 134] [Cited by in F6Publishing: 78] [Article Influence: 12.2] [Reference Citation Analysis]
286 Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ. The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience 2007;148:34-43. [PMID: 17618058 DOI: 10.1016/j.neuroscience.2007.05.029] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
287 Luppi P, Clément O, Sapin E, Gervasoni D, Peyron C, Léger L, Salvert D, Fort P. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Medicine Reviews 2011;15:153-63. [DOI: 10.1016/j.smrv.2010.08.002] [Cited by in Crossref: 176] [Cited by in F6Publishing: 146] [Article Influence: 16.0] [Reference Citation Analysis]
288 Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76. [PMID: 19549926 DOI: 10.1124/pr.109.001321] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 26.2] [Reference Citation Analysis]
289 Weng HH, Chen CF, Tsai YH, Wu CY, Lee M, Lin YC, Yang CT, Tsai YH, Yang CY. Gray matter atrophy in narcolepsy: An activation likelihood estimation meta-analysis. Neurosci Biobehav Rev 2015;59:53-63. [PMID: 25825285 DOI: 10.1016/j.neubiorev.2015.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
290 Li Y, van den Pol AN. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 2006;26:13037-47. [PMID: 17167093 DOI: 10.1523/JNEUROSCI.3380-06.2006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
291 Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 2010;33:875-8. [PMID: 20614847 DOI: 10.1093/sleep/33.7.875] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.1] [Reference Citation Analysis]
292 Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006;26:13400-10. [PMID: 17182791 DOI: 10.1523/JNEUROSCI.4332-06.2006] [Cited by in Crossref: 308] [Cited by in F6Publishing: 153] [Article Influence: 20.5] [Reference Citation Analysis]
293 Jackson MW, Spencer NJ, Reed JH, Smith AJ, Gordon TP. Potentiation of a functional autoantibody in narcolepsy by a cholinesterase inhibitor. Lab Invest 2009;89:1332-9. [PMID: 19806080 DOI: 10.1038/labinvest.2009.108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
294 Prober DA. Discovery of Hypocretin/Orexin Ushers in a New Era of Sleep Research. Trends Neurosci 2018;41:70-2. [PMID: 29405929 DOI: 10.1016/j.tins.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
295 Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9. [PMID: 11830281 DOI: 10.1016/s0167-0115(01)00323-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
296 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
297 Dye TJ, Jain SV, Kothare SV. Central Hypersomnia. Semin Pediatr Neurol 2015;22:93-104. [PMID: 26072339 DOI: 10.1016/j.spen.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
298 Savvidou A, Knudsen S, Olsson-Engman M, Gammeltoft S, Jennum P, Palm L. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Sleep 2013;36:147-8. [PMID: 23288981 DOI: 10.5665/sleep.2320] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
299 Katsuki H, Akaike A. Excitotoxic degeneration of hypothalamic orexin neurons in slice culture. Neurobiology of Disease 2004;15:61-9. [DOI: 10.1016/j.nbd.2003.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
300 Sankararamakrishnan R. Recognition of GPCRs by Peptide Ligands and Membrane Compartments theory: Structural Studies of Endogenous Peptide Hormones in Membrane Environment. Bioscience Reports 2006;26:131-58. [DOI: 10.1007/s10540-006-9014-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
301 Kas MJ, Gelegen C, Schalkwyk LC, Collier DA. Interspecies comparisons of functional genetic variations and their implications in neuropsychiatry. Am J Med Genet 2009;150B:309-17. [DOI: 10.1002/ajmg.b.30815] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
302 Mitchell GC, Wang Q, Ramamoorthy P, Whim MD. A common single nucleotide polymorphism alters the synthesis and secretion of neuropeptide Y. J Neurosci 2008;28:14428-34. [PMID: 19118176 DOI: 10.1523/JNEUROSCI.0343-08.2008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
303 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
304 Krahn LE, Black JL, Silber MH. Narcolepsy: New Understanding of Irresistible Sleep. Mayo Clinic Proceedings 2001;76:185-94. [DOI: 10.1016/s0025-6196(11)63126-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
305 Arafat AM, Kaczmarek P, Skrzypski M, Pruszyńska-Oszmałek E, Kołodziejski P, Adamidou A, Ruhla S, Szczepankiewicz D, Sassek M, Billert M, Wiedenmann B, Pfeiffer AF, Nowak KW, Strowski MZ. Glucagon regulates orexin A secretion in humans and rodents. Diabetologia 2014;57:2108-16. [PMID: 25063274 DOI: 10.1007/s00125-014-3335-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
306 Roos R, Aziz N. Hypocretin-1 and secondary signs in Huntington's disease. Parkinsonism & Related Disorders 2007;13:S387-90. [DOI: 10.1016/s1353-8020(08)70035-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
307 Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004;24:6760-4. [PMID: 15282280 DOI: 10.1523/JNEUROSCI.1783-04.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
308 Sletten TL, Rajaratnam SM, Wright MJ, Zhu G, Naismith S, Martin NG, Hickie I. Genetic and environmental contributions to sleep-wake behavior in 12-year-old twins. Sleep 2013;36:1715-22. [PMID: 24179306 DOI: 10.5665/sleep.3136] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
309 Saper CB. Restoration: Potential for compensatory changes in numbers of neurons in adult human brain: Restoration. Ann Neurol 2013;74:762-4. [DOI: 10.1002/ana.24039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
310 Thorpe AJ, Cleary JP, Levine AS, Kotz CM. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) 2005;182:75-83. [PMID: 16075284 DOI: 10.1007/s00213-005-0040-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
311 Pizza F, Magnani M, Indrio C, Plazzi G. The hypocretin system and psychiatric disorders. Curr Psychiatry Rep 2014;16:433. [PMID: 24363104 DOI: 10.1007/s11920-013-0433-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
312 Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev. 2005;9:91-100. [PMID: 15737788 DOI: 10.1016/j.smrv.2004.06.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
313 Hauw JJ, Hausser-Hauw C, Hasboun D, Seilhean D. [The neuropathology of sleep in human neurodegenerative diseases]. Rev Neurol (Paris) 2008;164:669-82. [PMID: 18760429 DOI: 10.1016/j.neurol.2008.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
314 Sakurai T, Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011;32:451-62. [PMID: 21565412 DOI: 10.1016/j.tips.2011.03.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 136] [Article Influence: 12.6] [Reference Citation Analysis]
315 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
316 Jöhren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides 2002;23:1177-80. [DOI: 10.1016/s0196-9781(02)00052-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
317 Peyron C, Valentin F, Bayard S, Hanriot L, Bedetti C, Rousset B, Luppi P, Dauvilliers Y. Melanin concentrating hormone in central hypersomnia. Sleep Medicine 2011;12:768-72. [DOI: 10.1016/j.sleep.2011.04.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
318 Alam MN, Kumar S, Suntsova N, Bashir T, Szymusiak R, McGinty D. GABAergic regulation of the perifornical-lateral hypothalamic neurons during non-rapid eye movement sleep in rats. Neuroscience 2010;167:920-8. [PMID: 20188152 DOI: 10.1016/j.neuroscience.2010.02.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
319 Meerabux J, Iwayama Y, Sakurai T, Ohba H, Toyota T, Yamada K, Nagata R, Irukayama-tomobe Y, Shimizu H, Yoshitsugu K, Ohta K, Yoshikawa T. Association of An Orexin 1 Receptor 408Val Variant with Polydipsia–Hyponatremia in Schizophrenic Subjects. Biological Psychiatry 2005;58:401-7. [DOI: 10.1016/j.biopsych.2005.04.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
320 Thompson MD, Siminovitch KA, Cole DEC. G Protein-Coupled Receptor Pharmacogenetics. In: Yan Q, editor. Pharmacogenomics in Drug Discovery and Development. Totowa: Humana Press; 2008. pp. 139-85. [DOI: 10.1007/978-1-59745-205-2_8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
321 Swaab D. The human hypothalamus in metabolic and episodic disorders. Hypothalamic Integration of Energy Metabolism, Proceedings of the 24th International Summer School of Brain Research, held at the Royal Netherlands Academy of Arts and Sciences. Elsevier; 2006. pp. 3-45. [DOI: 10.1016/s0079-6123(06)53001-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
322 Blumberg MS. Sleep physiology: setting the right tone. Curr Biol 2013;23:R834-6. [PMID: 24070441 DOI: 10.1016/j.cub.2013.07.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
323 Melzi S, Morel AL, Scoté-Blachon C, Liblau R, Dauvilliers Y, Peyron C. Histamine in murine narcolepsy: What do genetic and immune models tell us? Brain Pathol 2021;:e13027. [PMID: 34672414 DOI: 10.1111/bpa.13027] [Reference Citation Analysis]
324 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
325 Rai S, Kumar S, Alam MA, Szymusiak R, McGinty D, Alam MN. A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats. Neuroscience 2010;167:40-8. [PMID: 20109537 DOI: 10.1016/j.neuroscience.2010.01.044] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
326 de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
327 Ton TG, Longstreth WT Jr, Koepsell TD. Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602. Environ Res 2010;110:565-70. [PMID: 20519130 DOI: 10.1016/j.envres.2010.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
328 Silver R, Lesauter J. Circadian and homeostatic factors in arousal. Ann N Y Acad Sci 2008;1129:263-74. [PMID: 18591487 DOI: 10.1196/annals.1417.032] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
329 Bioulac S, Micoulaud-franchi J, Philip P. Excessive Daytime Sleepiness in Patients With ADHD—Diagnostic and Management Strategies. Curr Psychiatry Rep 2015;17. [DOI: 10.1007/s11920-015-0608-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
330 Lyons DJ, Hellysaz A, Ammari R, Broberger C. Hypocretin/Orexin Peptides Excite Rat Neuroendocrine Dopamine Neurons through Orexin 2 Receptor-Mediated Activation of a Mixed Cation Current. Sci Rep 2017;7:41535. [PMID: 28145492 DOI: 10.1038/srep41535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
331 Horjales-Araujo E, Hellysaz A, Broberger C. Lateral hypothalamic thyrotropin-releasing hormone neurons: distribution and relationship to histochemically defined cell populations in the rat. Neuroscience 2014;277:87-102. [PMID: 24993479 DOI: 10.1016/j.neuroscience.2014.06.043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
332 Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE, Iranzo A, Santamaria J, Peraita Adrados R, Vicario JL, Overeem S, Arnulf I, Theodorou I, Jennum P, Knudsen S, Bassetti C, Mathis J, Lecendreux M, Mayer G, Geisler P, Benetó A, Petit B, Pfister C, Bürki JV, Didelot G, Billiard M, Ercilla G, Verduijn W, Claas FH, Vollenweider P, Waeber G, Waterworth DM, Mooser V, Heinzer R, Beckmann JS, Bergmann S, Tafti M. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010;42:786-9. [PMID: 20711174 DOI: 10.1038/ng.647] [Cited by in Crossref: 139] [Cited by in F6Publishing: 114] [Article Influence: 11.6] [Reference Citation Analysis]
333 Bergman P, Adori C, Vas S, Kai-Larsen Y, Sarkanen T, Cederlund A, Agerberth B, Julkunen I, Horvath B, Kostyalik D, Kalmár L, Bagdy G, Huutoniemi A, Partinen M, Hökfelt T. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci U S A 2014;111:E3735-44. [PMID: 25136085 DOI: 10.1073/pnas.1412189111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
334 Kaur S, Thankachan S, Begum S, Liu M, Blanco-Centurion C, Shiromani PJ. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice. PLoS One 2009;4:e6346. [PMID: 19623260 DOI: 10.1371/journal.pone.0006346] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
335 Thorpe AJ, Mullett MA, Wang C, Kotz CM. Regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2003;284:R1409-17. [DOI: 10.1152/ajpregu.00344.2002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
336 Héricé C, Patel AA, Sakata S. Circuit mechanisms and computational models of REM sleep. Neurosci Res 2019;140:77-92. [PMID: 30118737 DOI: 10.1016/j.neures.2018.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
337 Faraco JH, Appelbaum L, Marin W, Gaus SE, Mourrain P, Mignot E. Regulation of hypocretin (orexin) expression in embryonic zebrafish. J Biol Chem 2006;281:29753-61. [PMID: 16867991 DOI: 10.1074/jbc.M605811200] [Cited by in Crossref: 80] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
338 Mori T, Ito S, Kuwaki T, Yanagisawa M, Sakurai T, Sawaguchi T. Monoaminergic neuronal changes in orexin deficient mice. Neuropharmacology 2010;58:826-32. [DOI: 10.1016/j.neuropharm.2009.08.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
339 Sarkanen TO, Alakuijala APE, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med Rev 2018;38:177-86. [PMID: 28847694 DOI: 10.1016/j.smrv.2017.06.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 16.6] [Reference Citation Analysis]
340 Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46-57. [PMID: 16507882 DOI: 10.1124/pr.58.1.4] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 7.0] [Reference Citation Analysis]
341 Arbuthnott G, Garcia-muñoz M. Neuropharmacology. Companion to Psychiatric Studies. Elsevier; 2010. pp. 45-76. [DOI: 10.1016/b978-0-7020-3137-3.00003-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
342 Overeem S, Kok SW, Lammers GJ, Vein AA, Frölich M, Meinders AE, Roelfsema F, Pijl H. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab 2003;284:E641-7. [PMID: 12453828 DOI: 10.1152/ajpendo.00421.2002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
343 Schirmacher A, Hor H, Heidbreder A, Happe S, Kelsch R, Kuhlenbäumer G, Meißner T, Mayer G, Young P. Sequence variants in circadian rhythmic genes in a cohort of patients suffering from hypersomnia of central origin. Biological Rhythm Research 2011;42:407-16. [DOI: 10.1080/09291016.2010.525382] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
344 van der Meijden WP, Fronczek R, Reijntjes RHAM, Corssmit EPM, Biermasz NR, Lammers GJ, van Dijk JG, Thijs RD. Time- and state-dependent analysis of autonomic control in narcolepsy: higher heart rate with normal heart rate variability independent of sleep fragmentation. J Sleep Res 2015;24:206-14. [DOI: 10.1111/jsr.12253] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
345 Inui A. Neuropeptide gene polymorphisms and human behavioural disorders. Nat Rev Drug Discov 2003;2:986-98. [DOI: 10.1038/nrd1252] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
346 Sykes N, Beirne P, Horowitz A, Jones I, Kalof L, Karlsson E, King T, Litwak H, McDonald RA, Murphy LJ, Pemberton N, Promislow D, Rowan A, Stahl PW, Tehrani J, Tourigny E, Wynne CDL, Strauss E, Larson G. Humanity's Best Friend: A Dog-Centric Approach to Addressing Global Challenges. Animals (Basel) 2020;10:E502. [PMID: 32192138 DOI: 10.3390/ani10030502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
347 Coleman PJ, Renger JJ. Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin Ther Pat 2010;20:307-24. [PMID: 20180618 DOI: 10.1517/13543770903567085] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
348 Hoever P, de Haas SL, Dorffner G, Chiossi E, van Gerven JM, Dingemanse J. Orexin receptor antagonism: an ascending multiple-dose study with almorexant. J Psychopharmacol 2012;26:1071-80. [DOI: 10.1177/0269881112448946] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
349 Abbott SM, Videnovic A. Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nat Sci Sleep 2016;8:55-61. [PMID: 26869817 DOI: 10.2147/NSS.S78947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
350 Krahn LE, Black JL, Silber MH. Narcolepsy: New Understanding of Irresistible Sleep. Mayo Clinic Proceedings 2001;76:185-94. [DOI: 10.4065/76.2.185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
351 Bartolini I, Pizza F, Di Luzio A, Neccia G, Antelmi E, Vandi S, Plazzi G. Automatic detection of cataplexy. Sleep Med 2018;52:7-13. [PMID: 30195199 DOI: 10.1016/j.sleep.2018.07.018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
352 Mistlberger RE. Circadian regulation of sleep in mammals: Role of the suprachiasmatic nucleus. Brain Research Reviews 2005;49:429-54. [DOI: 10.1016/j.brainresrev.2005.01.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 173] [Article Influence: 12.0] [Reference Citation Analysis]
353 Di Sebastiano AR, Coolen LM. Orexin and natural reward. Orexin/Hypocretin System. Elsevier; 2012. pp. 65-77. [DOI: 10.1016/b978-0-444-59489-1.00006-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
354 Sakurai T, Nagata R, Yamanaka A, Kawamura H, Tsujino N, Muraki Y, Kageyama H, Kunita S, Takahashi S, Goto K, Koyama Y, Shioda S, Yanagisawa M. Input of Orexin/Hypocretin Neurons Revealed by a Genetically Encoded Tracer in Mice. Neuron 2005;46:297-308. [DOI: 10.1016/j.neuron.2005.03.010] [Cited by in Crossref: 322] [Cited by in F6Publishing: 323] [Article Influence: 18.9] [Reference Citation Analysis]
355 Fontana A, Gast H, Reith W, Recher M, Birchler T, Bassetti CL. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain. 2010;133:1300-1311. [PMID: 20403960 DOI: 10.1093/brain/awq086] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
356 White EC, de Lahunta A. Narcolepsy in a ram lamb. Vet Rec 2001;149:156-7. [PMID: 11517987 DOI: 10.1136/vr.149.5.156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
357 Goldbart A, Peppard P, Finn L, Ruoff CM, Barnet J, Young T, Mignot E. Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep 2014;37:1043-51. [PMID: 24882899 DOI: 10.5665/sleep.3758] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 9.0] [Reference Citation Analysis]
358 Liu M, Thankachan S, Kaur S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Neve R, Shiromani PJ. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 2008;28:1382-93. [PMID: 18973565 DOI: 10.1111/j.1460-9568.2008.06446.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
359 Donga E, Romijn JA. Sleep characteristics and insulin sensitivity in humans. Handb Clin Neurol 2014;124:107-14. [PMID: 25248582 DOI: 10.1016/B978-0-444-59602-4.00007-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
360 Nagahara T, Saitoh T, Kutsumura N, Irukayama-Tomobe Y, Ogawa Y, Kuroda D, Gouda H, Kumagai H, Fujii H, Yanagisawa M, Nagase H. Design and Synthesis of Non-Peptide, Selective Orexin Receptor 2 Agonists. J Med Chem 2015;58:7931-7. [PMID: 26267383 DOI: 10.1021/acs.jmedchem.5b00988] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
361 Bayard S, Dauvilliers YA. Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy. Front Behav Neurosci 2013;7:50. [PMID: 23734110 DOI: 10.3389/fnbeh.2013.00050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
362 Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, Leger L, Fort P. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris 2006;100:271-83. [PMID: 17689057 DOI: 10.1016/j.jphysparis.2007.05.006] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
363 Leu-Semenescu S, De Cock VC, Le Masson VD, Debs R, Lavault S, Roze E, Vidailhet M, Arnulf I. Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson's disease. Sleep Med 2011;12:497-504. [PMID: 21486708 DOI: 10.1016/j.sleep.2011.03.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
364 de Zambotti M, Pizza F, Covassin N, Vandi S, Cellini N, Stegagno L, Plazzi G. Facing emotions in narcolepsy with cataplexy: haemodynamic and behavioural responses during emotional stimulation. J Sleep Res 2014;23:432-40. [DOI: 10.1111/jsr.12133] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
365 Kohlmeier KA, Inoue T, Leonard CS. Hypocretin/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and laterodorsal tegmentum. J Neurophysiol. 2004;92:221-235. [PMID: 14999052 DOI: 10.1152/jn.00076.2004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 3.9] [Reference Citation Analysis]
366 Mitler MM, Hayduk R. Benefits and Risks of Pharmacotherapy for Narcolepsy: . Drug Safety 2002;25:791-809. [DOI: 10.2165/00002018-200225110-00004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
367 Müller HL. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of the literature and perspectives. Int J Endocrinol 2010;2010:519607. [PMID: 21234339 DOI: 10.1155/2010/519607] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
368 Fukunaka Y, Shinkai T, Hwang R, Hori H, Utsunomiya K, Sakata S, Naoe Y, Shimizu K, Matsumoto C, Ohmori O, Nakamura J. The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia. Neuromolecular Med 2007;9:292-7. [PMID: 17999203 DOI: 10.1007/s12017-007-8001-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
369 Blanco-Centurion C, Gerashchenko D, Shiromani PJ. Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake. J Neurosci 2007;27:14041-8. [PMID: 18094243 DOI: 10.1523/JNEUROSCI.3217-07.2007] [Cited by in Crossref: 90] [Cited by in F6Publishing: 61] [Article Influence: 6.4] [Reference Citation Analysis]
370 Dauvilliers Y, Carlander B, Billiard M. La narcolepsie, de Westphal à l’hypocrétine. La Presse Médicale 2004;33:1593-600. [DOI: 10.1016/s0755-4982(04)99000-8] [Reference Citation Analysis]
371 Nevárez N, de Lecea L. Hypocretin and the Regulation of Sleep-Wake Transitions. Handbook of Sleep Research. Elsevier; 2019. pp. 89-99. [DOI: 10.1016/b978-0-12-813743-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
372 Kilduff TS. Hypocretin/orexin: maintenance of wakefulness and a multiplicity of other roles. Sleep Med Rev 2005;9:227-30. [PMID: 15998593 DOI: 10.1016/j.smrv.2005.04.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
373 Toyoda H, Honda Y, Tanaka S, Miyagawa T, Honda M, Honda K, Tokunaga K, Kodama T. Narcolepsy susceptibility gene CCR3 modulates sleep-wake patterns in mice. PLoS One 2017;12:e0187888. [PMID: 29186205 DOI: 10.1371/journal.pone.0187888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
374 McGregor R, Wu MF, Barber G, Ramanathan L, Siegel JM. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J Neurosci 2011;31:15455-67. [PMID: 22031892 DOI: 10.1523/JNEUROSCI.4017-11.2011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
375 Tesoriero C, Del Gallo F, Bentivoglio M. Sleep and brain infections. Brain Res Bull 2019;145:59-74. [PMID: 30016726 DOI: 10.1016/j.brainresbull.2018.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
376 Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
377 Mainieri G, Montini A, Nicotera A, Di Rosa G, Provini F, Loddo G. The Genetics of Sleep Disorders in Children: A Narrative Review. Brain Sci 2021;11:1259. [PMID: 34679324 DOI: 10.3390/brainsci11101259] [Reference Citation Analysis]
378 Pearl PL. Childhood sleep disorders: Diagnostic and therapeutic approaches. Curr Neurol Neurosci Rep 2002;2:150-7. [DOI: 10.1007/s11910-002-0024-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
379 Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 2014;37:1601-8. [PMID: 25197808 DOI: 10.5665/sleep.4066] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
380 Takahashi K, Arihara Z, Suzuki T, Sone M, Kikuchi K, Sasano H, Murakami O, Totsune K. Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine. Peptides 2006;27:871-7. [PMID: 16202475 DOI: 10.1016/j.peptides.2005.08.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
381 Kaushik MK, Aritake K, Imanishi A, Kanbayashi T, Ichikawa T, Shimizu T, Urade Y, Yanagisawa M. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc Natl Acad Sci U S A 2018;115:6046-51. [PMID: 29784823 DOI: 10.1073/pnas.1722686115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
382 Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77. [PMID: 15128861 DOI: 10.1523/JNEUROSCI.5560-03.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
383 Aziz A, Fronczek R, Maat-Schieman M, Unmehopa U, Roelandse F, Overeem S, van Duinen S, Lammers GJ, Swaab D, Roos R. Hypocretin and melanin-concentrating hormone in patients with Huntington disease. Brain Pathol 2008;18:474-83. [PMID: 18498421 DOI: 10.1111/j.1750-3639.2008.00135.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 38] [Article Influence: 0.9] [Reference Citation Analysis]
384 Nishino S, Mignot E. Wake-Promoting Medications: Basic Mechanisms and Pharmacology. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 468-83. [DOI: 10.1016/b0-72-160797-7/50045-8] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
385 Draganski B, Geisler P, Hajak G, Schuierer G, Bogdahn U, Winkler J, May A. Hypothalamic gray matter changes in narcoleptic patients. Nat Med 2002;8:1186-8. [DOI: 10.1038/nm1102-1186] [Cited by in Crossref: 78] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
386 Latorre D, Federica S, Bassetti CLA, Kallweit U. Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation. Semin Immunopathol 2022. [PMID: 35445831 DOI: 10.1007/s00281-022-00933-9] [Reference Citation Analysis]
387 Martin G, Fabre V, Siggins GR, de Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept 2002;104:111-7. [PMID: 11830285 DOI: 10.1016/s0167-0115(01)00354-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
388 Dijk DJ, von Schantz M. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J Biol Rhythms 2005;20:279-90. [PMID: 16077148 DOI: 10.1177/0748730405278292] [Cited by in Crossref: 135] [Cited by in F6Publishing: 120] [Article Influence: 7.9] [Reference Citation Analysis]
389 Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
390 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
391 Adamantidis A, de Lecea L. The hypocretins as sensors for metabolism and arousal. J Physiol 2009;587:33-40. [PMID: 19047201 DOI: 10.1113/jphysiol.2008.164400] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
392 Sturzenegger C, Baumann CR, Lammers GJ, Kallweit U, van der Zande WL, Bassetti CL. Swiss Narcolepsy Scale: A simple screening tool for hypocretin-deficient narcolepsy with cataplexy. Clinical and Translational Neuroscience 2018;2:2514183X1879417. [DOI: 10.1177/2514183x18794175] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
393 Brisbare-roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5. [DOI: 10.1038/nm1544] [Cited by in Crossref: 396] [Cited by in F6Publishing: 371] [Article Influence: 26.4] [Reference Citation Analysis]
394 Church GM. New technologies for integrating genomic, environmental and trait data. J Clin Sleep Med 2011;7:S43-4. [PMID: 22003332 DOI: 10.5664/JCSM.1362] [Reference Citation Analysis]
395 Eban-Rothschild A, de Lecea L. Neuronal substrates for initiation, maintenance, and structural organization of sleep/wake states. F1000Res 2017;6:212. [PMID: 28357049 DOI: 10.12688/f1000research.9677.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
396 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
397 Jiang W, Birtley JR, Hung SC, Wang W, Chiou SH, Macaubas C, Kornum B, Tian L, Huang H, Adler L, Weaver G, Lu L, Ilstad-Minnihan A, Somasundaram S, Ayyangar S, Davis MM, Stern LJ, Mellins ED. In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. Nat Commun 2019;10:5247. [PMID: 31748512 DOI: 10.1038/s41467-019-13234-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
398 Chowdhury T, Bindu B, Singh GP, Schaller B. Sleep Disorders: Is the Trigemino-Cardiac Reflex a Missing Link? Front Neurol 2017;8:63. [PMID: 28289401 DOI: 10.3389/fneur.2017.00063] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
399 Shimada M, Miyagawa T, Kawashima M, Tanaka S, Honda Y, Honda M, Tokunaga K. An approach based on a genome-wide association study reveals candidate loci for narcolepsy. Hum Genet 2010;128:433-41. [PMID: 20677014 DOI: 10.1007/s00439-010-0862-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
400 Tanaka S. Transcriptional regulation of the hypocretin/orexin gene. Vitam Horm 2012;89:75-90. [PMID: 22640609 DOI: 10.1016/B978-0-12-394623-2.00005-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
401 Lammers GJ. Intranasal hypocretin-1: making sense of scents? Sleep Med 2011;12:939-40. [PMID: 22136855 DOI: 10.1016/j.sleep.2011.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
402 Leone M, Mea E, Genco S, Bussone G. Coexistence of TACS and Trigeminal Neuralgia: Pathophysiological Conjectures. Headache 2006;46:1565-70. [DOI: 10.1111/j.1526-4610.2006.00537.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
403 Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M, Serafin M. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 2002;22:7835-9. [PMID: 12223534 [PMID: 12223534 DOI: 10.1523/jneurosci.22-18-07835.2002] [Cited by in Crossref: 107] [Article Influence: 5.4] [Reference Citation Analysis]
404 Liu M, Min T, Zhang H, Liu Y, Wang Z. Pharmacological Characteristics of Porcine Orexin 2 Receptor and Mutants. Front Endocrinol (Lausanne) 2020;11:132. [PMID: 32296386 DOI: 10.3389/fendo.2020.00132] [Reference Citation Analysis]
405 Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, Siegel JM. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-6. [PMID: 12097478 DOI: 20026541] [Cited by in Crossref: 224] [Article Influence: 11.2] [Reference Citation Analysis]
406 Oishi Y, Williams RH, Agostinelli L, Arrigoni E, Fuller PM, Mochizuki T, Saper CB, Scammell TE. Role of the medial prefrontal cortex in cataplexy. J Neurosci 2013;33:9743-51. [PMID: 23739971 DOI: 10.1523/JNEUROSCI.0499-13.2013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
407 Nakamachi T, Endo S, Ohtaki H, Yin L, Kenji D, Kudo Y, Funahashi H, Matsuda K, Shioda S. Orexin-1 receptor expression after global ischemia in mice. Regul Pept 2005;126:49-54. [PMID: 15620413 DOI: 10.1016/j.regpep.2004.08.037] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
408 Raizen DM, Wu MN. Genome-wide association studies of sleep disorders. Chest 2011;139:446-52. [PMID: 21285061 DOI: 10.1378/chest.10-1313] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
409 Arango M, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacological Research 2015;92:6-12. [DOI: 10.1016/j.phrs.2014.10.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
410 DeMartinis NA, Kamath J, Winokur A. New approaches for the treatment of sleep disorders. Adv Pharmacol 2009;57:187-235. [PMID: 20230762 DOI: 10.1016/S1054-3589(08)57005-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
411 Bernard-Valnet R, Yshii L, Quériault C, Nguyen XH, Arthaud S, Rodrigues M, Canivet A, Morel AL, Matthys A, Bauer J, Pignolet B, Dauvilliers Y, Peyron C, Liblau RS. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A 2016;113:10956-61. [PMID: 27621438 DOI: 10.1073/pnas.1603325113] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
412 Ebrahim IO, Howard RS, Kopelman MD, Sharief MK, Williams AJ. The hypocretin/orexin system. J R Soc Med 2002;95:227-30. [PMID: 11983761 DOI: 10.1258/jrsm.95.5.227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
413 Deboer T. Sleep homeostasis and the circadian clock: Do the circadian pacemaker and the sleep homeostat influence each other's functioning? Neurobiol Sleep Circadian Rhythms 2018;5:68-77. [PMID: 31236513 DOI: 10.1016/j.nbscr.2018.02.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
414 Sakurai T. Roles of orexins in regulation of feeding and wakefulness: . Neuroreport 2002;13:987-95. [DOI: 10.1097/00001756-200206120-00001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
415 Mieda M, Sakurai T. Overview of orexin/hypocretin system. Orexin/Hypocretin System. Elsevier; 2012. pp. 5-14. [DOI: 10.1016/b978-0-444-59489-1.00002-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
416 Matsuki T, Nomiyama M, Takahira H, Hirashima N, Kunita S, Takahashi S, Yagami K, Kilduff TS, Bettler B, Yanagisawa M, Sakurai T. Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture. Proc Natl Acad Sci U S A 2009;106:4459-64. [PMID: 19246384 DOI: 10.1073/pnas.0811126106] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 6.2] [Reference Citation Analysis]
417 Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neuroscience Letters 2003;341:13-6. [DOI: 10.1016/s0304-3940(03)00085-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
418 Bonaventure P, Shelton J, Yun S, Nepomuceno D, Sutton S, Aluisio L, Fraser I, Lord B, Shoblock J, Welty N, Chaplan SR, Aguilar Z, Halter R, Ndifor A, Koudriakova T, Rizzolio M, Letavic M, Carruthers NI, Lovenberg T, Dugovic C. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia. J Pharmacol Exp Ther 2015;354:471-82. [PMID: 26177655 DOI: 10.1124/jpet.115.225466] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
419 Zhang M, Inocente CO, Villanueva C, Lecendreux M, Dauvilliers Y, Lin JS, Arnulf I, Gustin MP, Thieux M, Franco P. Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture? CNS Neurosci Ther 2020. [PMID: 32761857 DOI: 10.1111/cns.13438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
420 Kövari E, Hof PR, Bouras C. The Geneva brain collection. Ann N Y Acad Sci 2011;1225 Suppl 1:E131-46. [PMID: 21599692 DOI: 10.1111/j.1749-6632.2011.06008.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
421 Pontual LD, Trochet D, Caillat-zucman S, Shenab OAA, Bougneres P, Crow Y, Cunningham S, Esteva B, Heberle LC, Leger J, Pinto G, Polak M, Shafik MH, Straus C, Trang H, Munnich A, Lyonnet S, Desguerre I, Amiel J. Delineation of Late Onset Hypoventilation Associated with Hypothalamic Dysfunction Syndrome. Pediatr Res 2008;64:689-94. [DOI: 10.1203/pdr.0b013e318187dd0e] [Cited by in Crossref: 44] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
422 Black JL, Silber MH, Krahn LE, Avula RK, Walker DL, Pankratz VS, Fredrickson PA, Slocumb NL. Studies of Humoral Immunity to Preprohypocretin in Human Leukocyte Antigen DQB1*0602–Positive Narcoleptic Subjects with Cataplexy. Biological Psychiatry 2005;58:504-9. [DOI: 10.1016/j.biopsych.2005.04.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
423 Peever JH, Lai YY, Siegel JM. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003;89:2591-600. [PMID: 12611960 DOI: 10.1152/jn.00968.2002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
424 Stamelou M, Plazzi G, Lugaresi E, Edwards MJ, Bhatia KP. The distinct movement disorder in anti-NMDA receptor encephalitis may be related to status dissociatus: A hypothesis. Mov Disord 2012;27:1360-3. [DOI: 10.1002/mds.25072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
425 Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami Ki, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13. [PMID: 12797956 DOI: 10.1016/s0896-6273(03)00331-3] [Cited by in Crossref: 595] [Cited by in F6Publishing: 310] [Article Influence: 31.3] [Reference Citation Analysis]
426 López M, Tena-Sempere M, Diéguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010;31:113-27. [PMID: 19654017 DOI: 10.1016/j.yfrne.2009.07.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 4.0] [Reference Citation Analysis]
427 Iranzo A. Sleep and neurological autoimmune diseases. Neuropsychopharmacology 2020;45:129-40. [PMID: 31302665 DOI: 10.1038/s41386-019-0463-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
428 Guilleminault C, Brooks S. Idiopathic hypersomnia: a neurological dilemma. Sleep Med Rev 2001;5:347-9. [PMID: 12530997 DOI: 10.1053/smrv.2001.0210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
429 Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004;24:7159-66. [PMID: 15306649 DOI: 10.1523/JNEUROSCI.1027-04.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
430 Bertels Z, Pradhan AAA. Emerging Treatment Targets for Migraine and Other Headaches. Headache 2019;59 Suppl 2:50-65. [PMID: 31291018 DOI: 10.1111/head.13585] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
431 Barateau L, Lopez R, Dauvilliers Y. Clinical neurophysiology of CNS hypersomnias. Handb Clin Neurol 2019;161:353-67. [PMID: 31307613 DOI: 10.1016/B978-0-444-64142-7.00060-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
432 John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 2003;548:557-62. [PMID: 12626669 DOI: 10.1113/jphysiol.2002.038729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
433 Katagiri A, Okamoto K, Thompson R, Rahman M, Bereiter DA. Posterior hypothalamic modulation of ocular-responsive trigeminal subnucleus caudalis neurons is mediated by Orexin-A and Orexin1 receptors. Eur J Neurosci 2014;40:2619-27. [PMID: 24904977 DOI: 10.1111/ejn.12635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
434 Cao M, Guilleminault C. Hypocretin and its emerging role as a target for treatment of sleep disorders. Curr Neurol Neurosci Rep 2011;11:227-34. [PMID: 21170610 DOI: 10.1007/s11910-010-0172-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
435 Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Plazzi G, Pizza F. Sleep dynamics beyond traditional sleep macrostructure. Sleep 2013;36:1123-4. [PMID: 23904669 DOI: 10.5665/sleep.2864] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
437 Martínez-rodríguez JE, Santamaria J. CSF markers in sleep neurobiology. Clinica Chimica Acta 2005;362:12-25. [DOI: 10.1016/j.cccn.2005.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
438 Fort P, Bassetti CL, Luppi P. Alternating vigilance states: new insights regarding neuronal networks and mechanisms. European Journal of Neuroscience 2009;29:1741-53. [DOI: 10.1111/j.1460-9568.2009.06722.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 70] [Article Influence: 7.4] [Reference Citation Analysis]
439 Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54. [PMID: 11394998 DOI: 10.1016/s0896-6273(01)00293-8] [Cited by in Crossref: 945] [Cited by in F6Publishing: 403] [Article Influence: 45.0] [Reference Citation Analysis]
440 Peyron C, Seugnet L, Lin JS. Commentary: A Quest for a Novel Peripheral Biomarker for Narcolepsy. CNS Neurosci Ther 2015;21:681-2. [PMID: 26281778 DOI: 10.1111/cns.12433] [Reference Citation Analysis]
441 Chabas D, Foulon C, Gonzalez J, Nasr M, Lyon-Caen O, Willer JC, Derenne JP, Arnulf I. Eating disorder and metabolism in narcoleptic patients. Sleep 2007;30:1267-73. [PMID: 17969460 DOI: 10.1093/sleep/30.10.1267] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
442 Bayon V, Léger D, Philip P. Socio-professional handicap and accidental risk in patients with hypersomnias of central origin. Sleep Medicine Reviews 2009;13:421-6. [DOI: 10.1016/j.smrv.2009.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
443 Burdakov D. K+ channels stimulated by glucose: a new energy-sensing pathway. Pflugers Arch - Eur J Physiol 2007;454:19-27. [DOI: 10.1007/s00424-006-0189-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
444 Sorensen GL, Knudsen S, Jennum P. Sleep transitions in hypocretin-deficient narcolepsy. Sleep 2013;36:1173-7. [PMID: 23904677 DOI: 10.5665/sleep.2880] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
445 Nishino S. Hypocretin/dopamine interaction in sleep-related motor function. Sleep and Biological Rhythms 2004;2:S11-2. [DOI: 10.1111/j.1479-8425.2004.00089.x] [Reference Citation Analysis]
446 Xi M, Morales FR, Chase MH. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Research 2001;901:259-64. [DOI: 10.1016/s0006-8993(01)02317-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
447 Berteotti C, Lo Martire V, Alvente S, Bastianini S, Bombardi C, Matteoli G, Ohtsu H, Lin JS, Silvani A, Zoccoli G. Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice. Front Neurosci 2021;15:660518. [PMID: 34093114 DOI: 10.3389/fnins.2021.660518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
448 Miyagawa T, Kawashima M, Nishida N, Ohashi J, Kimura R, Fujimoto A, Shimada M, Morishita S, Shigeta T, Lin L, Hong SC, Faraco J, Shin YK, Jeong JH, Okazaki Y, Tsuji S, Honda M, Honda Y, Mignot E, Tokunaga K. Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet 2008;40:1324-8. [PMID: 18820697 DOI: 10.1038/ng.231] [Cited by in Crossref: 107] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
449 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
450 Herring WJ, Connor KM, Snyder E, Snavely DB, Zhang Y, Hutzelmann J, Matzura-wolfe D, Benca RM, Krystal AD, Walsh JK, Lines C, Roth T, Michelson D. Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials. The American Journal of Geriatric Psychiatry 2017;25:791-802. [DOI: 10.1016/j.jagp.2017.03.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
451 Leung LC, Mourrain P. Sleep: Short Sleepers Should Keep Count of Their Hypocretin Neurons. Curr Biol 2018;28:R558-60. [PMID: 29738730 DOI: 10.1016/j.cub.2018.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
452 Goldbeter A, Leloup J. From circadian clock mechanism to sleep disorders and jet lag: Insights from a computational approach. Biochemical Pharmacology 2021;191:114482. [DOI: 10.1016/j.bcp.2021.114482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
453 Lambe EK, Aghajanian GK. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 2003;40:139-50. [PMID: 14527439 DOI: 10.1016/s0896-6273(03)00598-1] [Cited by in Crossref: 91] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
454 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
455 Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, Melberg A, Cornelio F, Urban AE, Pizza F, Poli F, Grubert F, Wieland T, Graf E, Hallmayer J, Strom TM, Mignot E. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012;21:2205-10. [PMID: 22328086 DOI: 10.1093/hmg/dds035] [Cited by in Crossref: 163] [Cited by in F6Publishing: 135] [Article Influence: 16.3] [Reference Citation Analysis]
456 Liu RJ, van den Pol AN, Aghajanian GK. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci 2002;22:9453-64. [PMID: 12417670 [PMID: 12417670 DOI: 10.1523/jneurosci.22-21-09453.2002] [Cited by in Crossref: 256] [Article Influence: 12.8] [Reference Citation Analysis]
457 Gohil A, Eugster E. Growth Hormone Deficiency and Excessive Sleepiness: A Case Report and Review of the Literature. Pediatr Endocrinol Rev 2019;17:41-6. [PMID: 31599135 DOI: 10.17458/per.vol17.2019.ge.ghdeficiencyandsleepiness] [Reference Citation Analysis]
458 Sakurai T, Yanagisawa M, Mieda M. Rodent Models of Human Narcolepsy-cataplexy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 27-38. [DOI: 10.1007/0-387-25446-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
459 Dohi K, Ripley B, Fujiki N, Ohtaki H, Shioda S, Aruga T, Nishino S. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH). Peptides 2005;26:2339-43. [PMID: 15893406 DOI: 10.1016/j.peptides.2005.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
460 Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001;21:1656-62. [PMID: 11222656 [PMID: 11222656 DOI: 10.1523/jneurosci.21-05-01656.2001] [Cited by in Crossref: 455] [Article Influence: 21.7] [Reference Citation Analysis]
461 Saper CB. Hypothalamus. The Human Nervous System. Elsevier; 2012. pp. 548-83. [DOI: 10.1016/b978-0-12-374236-0.10016-1] [Cited by in Crossref: 13] [Article Influence: 1.3] [Reference Citation Analysis]
462 . [Hypocretin neurotransmitter system and narcolepsy]. Vojnosanit Pregl 2008;65:393-6. [PMID: 18630134 DOI: 10.2298/vsp0805393l] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
463 Verret L, Goutagny R, Fort P, Cagnon L, Salvert D, Léger L, Boissard R, Salin P, Peyron C, Luppi PH. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 2003;4:19. [PMID: 12964948 DOI: 10.1186/1471-2202-4-19] [Cited by in Crossref: 297] [Cited by in F6Publishing: 270] [Article Influence: 15.6] [Reference Citation Analysis]
464 Clasadonte J, Scemes E, Wang Z, Boison D, Haydon PG. Connexin 43-Mediated Astroglial Metabolic Networks Contribute to the Regulation of the Sleep-Wake Cycle. Neuron 2017;95:1365-1380.e5. [PMID: 28867552 DOI: 10.1016/j.neuron.2017.08.022] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 15.2] [Reference Citation Analysis]
465 Tsujino N, Yamanaka A, Ichiki K, Muraki Y, Kilduff TS, Yagami K, Takahashi S, Goto K, Sakurai T. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J Neurosci 2005;25:7459-69. [PMID: 16093397 DOI: 10.1523/JNEUROSCI.1193-05.2005] [Cited by in Crossref: 92] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
466 Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Yanai K. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 2005;26:767-77. [PMID: 15808907 DOI: 10.1016/j.peptides.2005.01.001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 4.0] [Reference Citation Analysis]
467 Poirsier-Violle C, Abourra A, Baumann C, Perrin L, Capri Y, Mignot C, Passemard S, Drunat S, Verloes A. A de novo 17q21.2 duplication in a boy with developmental delay and dysmorphic features. Eur J Med Genet 2013;56:226-8. [PMID: 23337768 DOI: 10.1016/j.ejmg.2012.12.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
468 Overeem S, Reading P, Bassetti CL. Narcolepsy. Sleep Medicine Clinics 2012;7:263-81. [DOI: 10.1016/j.jsmc.2012.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
469 Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument. Mov Disord 2007;22:2386-93. [PMID: 17894337 DOI: 10.1002/mds.21740] [Cited by in Crossref: 474] [Cited by in F6Publishing: 434] [Article Influence: 33.9] [Reference Citation Analysis]
470 Ponziani V, Gennari M, Pizza F, Balsamo A, Bernardi F, Plazzi G. Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. J Clin Sleep Med 2016;12:1649-57. [PMID: 27707443 DOI: 10.5664/jcsm.6352] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
471 Wu M, Zaborszky L, Hajszan T, van den Pol AN, Alreja M. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons. J Neurosci 2004;24:3527-36. [PMID: 15071100 DOI: 10.1523/JNEUROSCI.5364-03.2004] [Cited by in Crossref: 102] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
472 Letavic MA, Bonaventure P, Carruthers NI, Dugovic C, Koudriakova T, Lord B, Lovenberg TW, Ly KS, Mani NS, Nepomuceno D, Pippel DJ, Rizzolio M, Shelton JE, Shah CR, Shireman BT, Young LK, Yun S. Novel Octahydropyrrolo[3,4- c ]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical Candidate. J Med Chem 2015;58:5620-36. [DOI: 10.1021/acs.jmedchem.5b00742] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
473 Arnulf I. Excessive daytime sleepiness in parkinsonism. Sleep Medicine Reviews 2005;9:185-200. [DOI: 10.1016/j.smrv.2005.01.001] [Cited by in Crossref: 146] [Cited by in F6Publishing: 118] [Article Influence: 8.6] [Reference Citation Analysis]
474 Bernardini C, Lattanzi W, Bosco P, Franceschini C, Plazzi G, Michetti F, Ferri R. Genome-wide gene expression profiling of human narcolepsy. Gene Expr 2012;15:171-81. [PMID: 22783726 DOI: 10.3727/105221612x13372578119652] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
475 Gerashchenko D, Murillo-rodriguez E, Lin L, Xu M, Hallett L, Nishino S, Mignot E, Shiromani PJ. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Experimental Neurology 2003;184:1010-6. [DOI: 10.1016/s0014-4886(03)00388-1] [Cited by in Crossref: 95] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
476 Monk TH, Welsh DK. The role of chronobiology in sleep disorders medicine. Sleep Medicine Reviews 2003;7:455-73. [DOI: 10.1016/s1087-0792(03)90001-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
477 Zhang JH, Sampogna S, Morales FR, Chase MH. Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem. Brain Res 2002;930:206-11. [PMID: 11879811 DOI: 10.1016/s0006-8993(02)02240-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
478 Chung H, Kim J, Kim J, Kim H, Yoon B. Orexin administration to mice that underwent chronic stress produces bimodal effects on emotion-related behaviors. Regulatory Peptides 2014;194-195:16-22. [DOI: 10.1016/j.regpep.2014.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
479 Preskorn SH. CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part I. J Psychiatr Pract 2014;20:460-5. [PMID: 25406050 DOI: 10.1097/01.pra.0000456594.66363.6f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
480 Liu M, Blanco-Centurion C, Shiromani PJ. Rewiring brain circuits to block cataplexy in murine models of narcolepsy. Curr Opin Neurobiol 2017;44:110-5. [PMID: 28445807 DOI: 10.1016/j.conb.2017.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
481 Lu J, Huang ML, Li JH, Jin KY, Li HM, Mou TT, Fronczek R, Duan JF, Xu WJ, Swaab D, Bao AM. Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain. Schizophr Bull 2021;47:1310-9. [PMID: 33974073 DOI: 10.1093/schbul/sbab042] [Reference Citation Analysis]
482 Peyron C, Kilduff TS. Mapping the Hypocretin/Orexin Neuronal System: An Unexpectedly Productive Journey. J Neurosci 2017;37:2268-72. [PMID: 28250055 DOI: 10.1523/JNEUROSCI.1708-16.2016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.6] [Reference Citation Analysis]
483 Dauvilliers Y, Jennum P, Plazzi G. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy. Sleep Med 2013;14:775-81. [PMID: 23219054 DOI: 10.1016/j.sleep.2012.10.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
484 Maruyama T, Matsumura M, Sakai N, Nishino S. The pathogenesis of narcolepsy, current treatments and prospective therapeutic targets. Expert Opinion on Orphan Drugs 2015;4:63-82. [DOI: 10.1517/21678707.2016.1117973] [Reference Citation Analysis]
485 Rodrigues Aguilar AC, Frange C, Huebra L, Dias Gomes AC, Tufik S, Santos Coelho FM. The effects of the COVID-19 pandemic on patients with narcolepsy. J Clin Sleep Med 2021;17:621-7. [PMID: 33124977 DOI: 10.5664/jcsm.8952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
486 Stephansen JB, Olesen AN, Olsen M, Ambati A, Leary EB, Moore HE, Carrillo O, Lin L, Han F, Yan H, Sun YL, Dauvilliers Y, Scholz S, Barateau L, Hogl B, Stefani A, Hong SC, Kim TW, Pizza F, Plazzi G, Vandi S, Antelmi E, Perrin D, Kuna ST, Schweitzer PK, Kushida C, Peppard PE, Sorensen HBD, Jennum P, Mignot E. Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy. Nat Commun 2018;9:5229. [PMID: 30523329 DOI: 10.1038/s41467-018-07229-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 19.5] [Reference Citation Analysis]
487 van den Pol AN, Ghosh PK, Liu RJ, Li Y, Aghajanian GK, Gao XB. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 2002;541:169-85. [PMID: 12015428 DOI: 10.1113/jphysiol.2002.017426] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 5.9] [Reference Citation Analysis]
488 Hor H, Bartesaghi L, Kutalik Z, Vicário JL, de Andrés C, Pfister C, Lammers GJ, Guex N, Chrast R, Tafti M, Peraita-Adrados R. A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am J Hum Genet 2011;89:474-9. [PMID: 21907016 DOI: 10.1016/j.ajhg.2011.08.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
489 Lang M, Bufe B, De Pol S, Reiser O, Meyerhof W, Beck-sickinger AG. Structural properties of orexins for activation of their receptors. J Peptide Sci 2006;12:258-66. [DOI: 10.1002/psc.716] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
490 Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, Honda Y, Inoko H, Tokunaga K. Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 2006;79:252-63. [PMID: 16826516 DOI: 10.1086/505539] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
491 Brown RE, Spratt TJ, Kaplan GB. Translational Approaches to Influence Sleep and Arousal. Brain Res Bull 2022:S0361-9230(22)00116-2. [PMID: 35550156 DOI: 10.1016/j.brainresbull.2022.05.002] [Reference Citation Analysis]
492 Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005;9:231-41. [PMID: 15961331 DOI: 10.1016/j.smrv.2004.07.007] [Cited by in Crossref: 196] [Cited by in F6Publishing: 172] [Article Influence: 11.5] [Reference Citation Analysis]
493 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
494 Thannickal TC, John J, Shan L, Swaab DF, Wu MF, Ramanathan L, McGregor R, Chew KT, Cornford M, Yamanaka A, Inutsuka A, Fronczek R, Lammers GJ, Worley PF, Siegel JM. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci Transl Med 2018;10:eaao4953. [PMID: 29950444 DOI: 10.1126/scitranslmed.aao4953] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
495 Petersén Å, Gil J, Maat-schieman ML, Björkqvist M, Tanila H, Araújo IM, Smith R, Popovic N, Wierup N, Norlén P, Li J, Roos RA, Sundler F, Mulder H, Brundin P. Orexin loss in Huntington's disease. Human Molecular Genetics 2005;14:39-47. [DOI: 10.1093/hmg/ddi004] [Cited by in Crossref: 183] [Cited by in F6Publishing: 168] [Article Influence: 10.2] [Reference Citation Analysis]
496 Han F. Sleepiness that cannot be overcome: Narcolepsy and cataplexy: Narcolepsy-cataplexy syndrome. Respirology 2012;17:1157-65. [DOI: 10.1111/j.1440-1843.2012.02178.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
497 Mahoney CE, Agostinelli LJ, Brooks JN, Lowell BB, Scammell TE. GABAergic Neurons of the Central Amygdala Promote Cataplexy. J Neurosci 2017;37:3995-4006. [PMID: 28235898 DOI: 10.1523/JNEUROSCI.4065-15.2017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
498 Galibert F, André C, Hitte C. Le chien, un modèle pour la génétique des mammifères. Med Sci (Paris) 2004;20:761-6. [DOI: 10.1051/medsci/2004208-9761] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
499 De la Herrán-Arita AK, Guerra-Crespo M, Drucker-Colín R. Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011;2:26. [PMID: 21541306 DOI: 10.3389/fneur.2011.00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
500 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
501 Van Den Pol AN, Patrylo PR, Ghosh PK, Gao X. Lateral hypothalamus: Early developmental expression and response to hypocretin (orexin). J Comp Neurol 2001;433:349-63. [DOI: 10.1002/cne.1144] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.1] [Reference Citation Analysis]
502 Yukitake H, Fujimoto T, Ishikawa T, Suzuki A, Shimizu Y, Rikimaru K, Ito M, Suzuki M, Kimura H. TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice. Pharmacology Biochemistry and Behavior 2019;187:172794. [DOI: 10.1016/j.pbb.2019.172794] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
503 Toyama S, Shimoyama N, Tagaito Y, Nagase H, Saitoh T, Yanagisawa M, Shimoyama M. Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats. Anesthesiology 2018;128:992-1003. [PMID: 29521652 DOI: 10.1097/ALN.0000000000002161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
504 Frederick-Duus D, Guyton MF, Fadel J. Food-elicited increases in cortical acetylcholine release require orexin transmission. Neuroscience 2007;149:499-507. [PMID: 17928158 DOI: 10.1016/j.neuroscience.2007.07.061] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
505 Quaedackers L, Overeem S, Pillen S. Two sides of a coin: differential response to COVID-19 distancing measures in children with narcolepsy. J Clin Sleep Med 2021;17:859-62. [PMID: 33295278 DOI: 10.5664/jcsm.9040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Nishino S, Mignot E. Narcolepsy and cataplexy. Sleep Disorders. Elsevier; 2011. pp. 783-814. [DOI: 10.1016/b978-0-444-52007-4.00007-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
507 Grimaldi D, Calandra-Buonaura G, Provini F, Agati P, Pierangeli G, Franceschini C, Barletta G, Plazzi G, Montagna P, Cortelli P. Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep 2012;35:519-28. [PMID: 22467990 DOI: 10.5665/sleep.1738] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
508 Flores Á, Valls-Comamala V, Costa G, Saravia R, Maldonado R, Berrendero F. The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology 2014;39:2732-41. [PMID: 24930888 DOI: 10.1038/npp.2014.146] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
509 Tafuri S, Muto RL, Pavone LM, Valiante S, Costagliola A, Staiano N, Vittoria A. Novel localization of orexin A in the tubular cytotypes of the rat testis. Regulatory Peptides 2010;164:53-7. [DOI: 10.1016/j.regpep.2010.06.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
510 Xie X, Crowder TL, Yamanaka A, Morairty SR, Lewinter RD, Sakurai T, Kilduff TS. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol 2006;574:399-414. [PMID: 16627567 DOI: 10.1113/jphysiol.2006.108266] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
511 Kas MJ, Van Elburg AA, Van Engeland H, Adan RA. Refinement of behavioural traits in animals for the genetic dissection of eating disorders. European Journal of Pharmacology 2003;480:13-20. [DOI: 10.1016/j.ejphar.2003.08.088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
512 Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002;290:1237-45. [PMID: 11811995 DOI: 10.1006/bbrc.2001.6318] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 10.1] [Reference Citation Analysis]
513 Haj-Dahmane S, Shen RY. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 2005;25:896-905. [PMID: 15673670 DOI: 10.1523/JNEUROSCI.3258-04.2005] [Cited by in Crossref: 96] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
514 Knudsen S, Gammeltoft S, Jennum PJ. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain 2010;133:568-79. [DOI: 10.1093/brain/awp320] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 6.6] [Reference Citation Analysis]
515 De La Herrán-Arita AK, Zomosa-Signoret VC, Millán-Aldaco DA, Palomero-Rivero M, Guerra-Crespo M, Drucker-Colín R, Vidaltamayo R. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice. Neuroscience 2011;183:134-43. [PMID: 21435382 DOI: 10.1016/j.neuroscience.2011.03.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
516 Hong ZY, Huang ZL, Qu WM, Eguchi N. Orexin A promotes histamine, but not norepinephrine or serotonin, release in frontal cortex of mice. Acta Pharmacol Sin 2005;26:155-9. [PMID: 15663891 DOI: 10.1111/j.1745-7254.2005.00523.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
517 Vassalli A, Li S, Tafti M. Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". Sci Transl Med 2015;7:314le2. [PMID: 26582896 DOI: 10.1126/scitranslmed.aad2353] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
518 Han F, Lin L, Li J, Dong SX, An P, Zhao L, Liu NY, Li QY, Yan H, Gao ZC, Faraco J, Strohl KP, Liu X, Miyadera H, Mignot E. HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 2012;80:328-35. [PMID: 22862152 DOI: 10.1111/j.1399-0039.2012.01948.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
519 España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001;106:699-715. [PMID: 11682157 DOI: 10.1016/s0306-4522(01)00319-0] [Cited by in Crossref: 218] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
520 Hoyer D, Dürst T, Fendt M, Jacobson LH, Betschart C, Hintermann S, Behnke D, Cotesta S, Laue G, Ofner S, Legangneux E, Gee CE. Distinct effects of IPSU and suvorexant on mouse sleep architecture. Front Neurosci 2013;7:235. [PMID: 24368893 DOI: 10.3389/fnins.2013.00235] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
521 Black SW, Sun JD, Santiago P, Laihsu A, Kimura N, Yamanaka A, Bersot R, Humphries PS. Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration. Sleep 2018;41. [DOI: 10.1093/sleep/zsy116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
522 Gauci S, Hosking W, Bruck D, Schumacher U. Narcolepsy, cataplexy, hypocretin and co-existing other health complaints: A review. Cogent Medicine 2017;4:1312791. [DOI: 10.1080/2331205x.2017.1312791] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
523 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
524 Black SW, Schwartz MD, Chen TM, Hoener MC, Kilduff TS. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry 2017;82:623-33. [PMID: 27919403 DOI: 10.1016/j.biopsych.2016.10.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
525 Kothare SV, Kaleyias J. Narcolepsy and other hypersomnias in children. Curr Opin Pediatr 2008;20:666-75. [PMID: 19023917 DOI: 10.1097/mop.0b013e328316bd85] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
526 Dresler M, Spoormaker V, Beitinger P, Czisch M, Kimura M, Steiger A, Holsboer F. Neuroscience-driven discovery and development of sleep therapeutics. Pharmacology & Therapeutics 2014;141:300-34. [DOI: 10.1016/j.pharmthera.2013.10.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
527 Knudsen S, Mikkelsen JD, Jennum P. Antibodies in narcolepsy–cataplexy patient serum bind to rat hypocretin neurons. NeuroReport 2007;18:77-9. [DOI: 10.1097/wnr.0b013e328010baad] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
528 von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, Grosshans M, Nakovics H, Wiedemann K, Mann K, Winterer G, Kiefer F. Orexin and leptin are associated with nicotine craving: A link between smoking, appetite and reward. Psychoneuroendocrinology 2010;35:570-7. [DOI: 10.1016/j.psyneuen.2009.09.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
529 Sakurai T. Roles of orexins in the regulation of body weight homeostasis. Obesity Research & Clinical Practice 2014;8:e414-20. [DOI: 10.1016/j.orcp.2013.12.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
530 De Lecea L, Sutcliffe JG. The hypocretins and sleep: The hypocretins and sleep. FEBS Journal 2005;272:5675-88. [DOI: 10.1111/j.1742-4658.2005.04981.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
531 Nishino S. The hypocretin/orexin system in health and disease. Biol Psychiatry 2003;54:87-95. [PMID: 12873797 DOI: 10.1016/s0006-3223(03)00349-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
532 Berteotti C, Silvani A. The link between narcolepsy and autonomic cardiovascular dysfunction: a translational perspective. Clin Auton Res 2018;28:545-55. [DOI: 10.1007/s10286-017-0473-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
533 Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol 2008;6:367-78. [PMID: 19587857 DOI: 10.2174/157015908787386050] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 12.5] [Reference Citation Analysis]
534 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
535 Ahmed SS, Steinman L. Mechanistic insights into influenza vaccine-associated narcolepsy. Hum Vaccin Immunother 2016;12:3196-201. [PMID: 27031682 DOI: 10.1080/21645515.2016.1171439] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
536 Li R, Faraco JH, Lin L, Lin X, Hinton L, Rogers W, Lowe JK, Ostrander EA, Mignot E. Physical and radiation hybrid mapping of canine chromosome 12, in a region corresponding to human chromosome 6p12-q12. Genomics 2001;73:299-315. [PMID: 11350122 DOI: 10.1006/geno.2000.6487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
537 Nellore A, Randall TD. Narcolepsy and influenza vaccination-the inappropriate awakening of immunity. Ann Transl Med 2016;4:S29. [PMID: 27867997 DOI: 10.21037/atm.2016.10.60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
538 Klein AB, Jennum P, Knudsen S, Gammeltoft S, Mikkelsen JD. Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsy. Neuroscience Letters 2013;544:31-5. [DOI: 10.1016/j.neulet.2013.03.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
539 Flygare J, Parthasarathy S. Narcolepsy: let the patient's voice awaken us! Am J Med 2015;128:10-3. [PMID: 24931392 DOI: 10.1016/j.amjmed.2014.05.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
540 Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011;21:897-903. [PMID: 21963829 DOI: 10.1016/j.conb.2011.09.003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 8.0] [Reference Citation Analysis]
541 Ritchie C, Okuro M, Kanbayashi T, Nishino S. Hypocretin ligand deficiency in narcolepsy: recent basic and clinical insights. Curr Neurol Neurosci Rep 2010;10:180-9. [PMID: 20425033 DOI: 10.1007/s11910-010-0100-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
542 Li Y, Gao X, Sakurai T, van den Pol AN. Hypocretin/Orexin Excites Hypocretin Neurons via a Local Glutamate Neuron—A Potential Mechanism for Orchestrating the Hypothalamic Arousal System. Neuron 2002;36:1169-81. [DOI: 10.1016/s0896-6273(02)01132-7] [Cited by in Crossref: 300] [Cited by in F6Publishing: 162] [Article Influence: 15.0] [Reference Citation Analysis]
543 Greene R, Siegel J. Sleep: a functional enigma. Neuromolecular Med 2004;5:59-68. [PMID: 15001813 DOI: 10.1385/NMM:5:1:059] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
544 Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-heier S. HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 2020;43:zsz239. [DOI: 10.1093/sleep/zsz239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
545 Tonokura M, Fujita K, Morozumi M, Yoshida Y, Kanbayashi T, Nishino S. Narcolepsy in a hypocretin/orexin-deficient chihuahua. Veterinary Record 2003;152:776-9. [DOI: 10.1136/vr.152.25.776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
546 Jones BE. Neurobiology of waking and sleeping. Handb Clin Neurol 2011;98:131-49. [PMID: 21056184 DOI: 10.1016/B978-0-444-52006-7.00009-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
547 Dauvilliers Y, Pennestri MH, Whittom S, Lanfranchi PA, Montplaisir JY. Autonomic response to periodic leg movements during sleep in narcolepsy-cataplexy. Sleep 2011;34:219-23. [PMID: 21286243 DOI: 10.1093/sleep/34.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
548 Katsuki H, Michinaga S. Anti-Parkinson drugs and orexin neurons. Vitam Horm 2012;89:279-90. [PMID: 22640619 DOI: 10.1016/B978-0-12-394623-2.00015-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
549 Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regulatory Peptides 2005;126:3-10. [DOI: 10.1016/j.regpep.2004.08.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
550 Dauvilliers Y, Lopez R, Ohayon M, Bayard S. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med 2013;11:78. [PMID: 23514569 DOI: 10.1186/1741-7015-11-78] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
551 Blechman J, Borodovsky N, Eisenberg M, Nabel-Rosen H, Grimm J, Levkowitz G. Specification of hypothalamic neurons by dual regulation of the homeodomain protein Orthopedia. Development 2007;134:4417-26. [PMID: 18003738 DOI: 10.1242/dev.011262] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
552 Wei W, Motoike T, Krzeszinski JY, Jin Z, Xie XJ, Dechow PC, Yanagisawa M, Wan Y. Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action. Cell Metab 2014;19:927-40. [PMID: 24794976 DOI: 10.1016/j.cmet.2014.03.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
553 Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Frontiers in Neuroendocrinology 2003;24:141-50. [DOI: 10.1016/s0091-3022(03)00028-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
554 Girault EM, Yi CX, Fliers E, Kalsbeek A. Orexins, feeding, and energy balance. Prog Brain Res 2012;198:47-64. [PMID: 22813969 DOI: 10.1016/B978-0-444-59489-1.00005-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
555 Baimel C, Borgland SL. Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse. Curr Top Behav Neurosci 2017;33:283-304. [PMID: 28303403 DOI: 10.1007/7854_2016_44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
556 Tafti M, Maret S, Dauvilliers Y. Genes for normal sleep and sleep disorders. Annals of Medicine 2009;37:580-9. [DOI: 10.1080/07853890500372047] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
557 Inutsuka A, Yamashita A, Chowdhury S, Nakai J, Ohkura M, Taguchi T, Yamanaka A. The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep 2016;6:29480. [PMID: 27385517 DOI: 10.1038/srep29480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
558 Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Göder R, Baier PC. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res 2014;262:8-13. [PMID: 24406723 DOI: 10.1016/j.bbr.2013.12.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
559 Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Mühlethaler M. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 2003;23:1557-62. [PMID: 12629156 [PMID: 12629156 DOI: 10.1523/jneurosci.23-05-01557.2003] [Cited by in Crossref: 113] [Article Influence: 5.9] [Reference Citation Analysis]
560 Alam MN, Kumar S, Bashir T, Suntsova N, Methippara MM, Szymusiak R, McGinty D. GABA-mediated control of hypocretin- but not melanin-concentrating hormone-immunoreactive neurones during sleep in rats. J Physiol 2005;563:569-82. [PMID: 15613374 DOI: 10.1113/jphysiol.2004.076927] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 5.6] [Reference Citation Analysis]
561 Oh Y, Jang D, Sonn JY, Choe J. Histamine-HisCl1 receptor axis regulates wake-promoting signals in Drosophila melanogaster. PLoS One 2013;8:e68269. [PMID: 23844178 DOI: 10.1371/journal.pone.0068269] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
562 Appelbaum L, Skariah G, Mourrain P, Mignot E. Comparative expression of p2x receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish. Brain Res 2007;1174:66-75. [PMID: 17868657 DOI: 10.1016/j.brainres.2007.06.103] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
563 Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, Lammers GJ. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004;62:138-40. [PMID: 14718718 DOI: 10.1212/01.wnl.0000101718.92619.67] [Cited by in Crossref: 85] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
564 Zhang S, Zeitzer JM, Sakurai T, Nishino S, Mignot E. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol 2007;581:649-63. [PMID: 17379635 DOI: 10.1113/jphysiol.2007.129510] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
565 Vaudano AE, Pizza F, Talami F, Plazzi G, Meletti S. The neuronal network of laughing in young patients with untreated narcolepsy. Neurology 2019:10. [PMID: 30635496 DOI: 10.1212/WNL.0000000000006853] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
566 Mignot E. Narcolepsy: Pharmacology, Pathophysiology, and Genetics. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 761-79. [DOI: 10.1016/b0-72-160797-7/50071-9] [Cited by in Crossref: 12] [Article Influence: 0.7] [Reference Citation Analysis]
567 Uramura K, Funahashi H, Muroya S, Shioda S, Takigawa M, Yada T. Orexin-a activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area. Neuroreport 2001;12:1885-9. [PMID: 11435917 DOI: 10.1097/00001756-200107030-00024] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 4.5] [Reference Citation Analysis]
568 Kilduff TS, Lein ES, de la Iglesia H, Sakurai T, Fu YH, Shaw P. New developments in sleep research: molecular genetics, gene expression, and systems neurobiology. J Neurosci 2008;28:11814-8. [PMID: 19005045 DOI: 10.1523/JNEUROSCI.3768-08.2008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
569 Sinton CM. Animal Models of Narcolepsy: Development, Findings and Perspectives. In: Goswami M, Pandi-perumal SR, Thorpy MJ, editors. Narcolepsy. New York: Springer; 2010. pp. 23-37. [DOI: 10.1007/978-1-4419-0854-4_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
570 Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, Cortelli P, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards MJ, Mignot E, Bhatia KP. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134:3477-89. [PMID: 21930661 DOI: 10.1093/brain/awr244] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 9.4] [Reference Citation Analysis]
571 Diederich NJ. [The neurology of REM sleep. A synoptic tour de force]. Nervenarzt 2007;78:406-17. [PMID: 17390120 DOI: 10.1007/s00115-006-2190-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
572 Yamanaka A, Muraki Y, Tsujino N, Goto K, Sakurai T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochemical and Biophysical Research Communications 2003;303:120-9. [DOI: 10.1016/s0006-291x(03)00299-7] [Cited by in Crossref: 154] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
573 Black J, Guilleminault C. Medications for the treatment of narcolepsy. Expert Opin Emerg Drugs 2001;6:239-47. [PMID: 15989524 DOI: 10.1517/14728214.6.2.239] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
574 Dauvilliers Y, Jaussent I, Krams B, Scholz S, Lado S, Levy P, Pepin JL. Non-dipping blood pressure profile in narcolepsy with cataplexy. PLoS One 2012;7:e38977. [PMID: 22768053 DOI: 10.1371/journal.pone.0038977] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
575 Luna SL, Brown DI, Eghlidi DH, Kohama SG, Urbanski HF. Locomotor activity and the expression of orexin A and orexin B in aged female rhesus macaques. Neurobiol Aging 2017;50:1-4. [PMID: 27837674 DOI: 10.1016/j.neurobiolaging.2016.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
576 Hallmayer J, Faraco J, Lin L, Hesselson S, Winkelmann J, Kawashima M, Mayer G, Plazzi G, Nevsimalova S, Bourgin P, Hong SC, Honda Y, Honda M, Högl B, Longstreth WT Jr, Montplaisir J, Kemlink D, Einen M, Chen J, Musone SL, Akana M, Miyagawa T, Duan J, Desautels A, Erhardt C, Hesla PE, Poli F, Frauscher B, Jeong JH, Lee SP, Ton TG, Kvale M, Kolesar L, Dobrovolná M, Nepom GT, Salomon D, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Young T, Peppard P, Tokunaga K, Kwok PY, Risch N, Mignot E. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009;41:708-11. [PMID: 19412176 DOI: 10.1038/ng.372] [Cited by in Crossref: 337] [Cited by in F6Publishing: 280] [Article Influence: 25.9] [Reference Citation Analysis]
577 Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ. Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Eur J Neurosci 2004;19:2741-52. [PMID: 15147308 DOI: 10.1111/j.0953-816X.2004.03366.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
578 Nevsimalova S, Buskova J, Kemlink D, Sonka K, Skibova J. Does age at the onset of narcolepsy influence the course and severity of the disease? Sleep Medicine 2009;10:967-72. [DOI: 10.1016/j.sleep.2009.01.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
579 Kornum BR, Knudsen S, Ollila HM, Pizza F, Jennum PJ, Dauvilliers Y, Overeem S. Narcolepsy. Nat Rev Dis Primers 2017;3:16100. [PMID: 28179647 DOI: 10.1038/nrdp.2016.100] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 21.8] [Reference Citation Analysis]
580 Caporali L, Moresco M, Pizza F, La Morgia C, Fiorini C, Strobbe D, Zenesini C, Hooshiar Kashani B, Torroni A, Pagotto U, Carelli V, Plazzi G. The role of mtDNA haplogroups on metabolic features in narcolepsy type 1. Mitochondrion 2022:S1567-7249(22)00005-8. [PMID: 35051655 DOI: 10.1016/j.mito.2022.01.005] [Reference Citation Analysis]
581 Elbaz I, Levitas-Djerbi T, Appelbaum L. The Hypocretin/Orexin Neuronal Networks in Zebrafish. Curr Top Behav Neurosci 2017;33:75-92. [PMID: 28012092 DOI: 10.1007/7854_2016_59] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
582 Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Sleep 2017;40. [PMID: 28364477 DOI: 10.1093/sleep/zsw010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
583 Sandsmark DK, Elliott JE, Lim MM. Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies. Sleep 2017;40. [PMID: 28329120 DOI: 10.1093/sleep/zsx044] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
584 Overeem S, Verschuuren JJ, Fronczek R, Schreurs L, den Hertog H, Hegeman-kleinn IM, van Duinen SG, Unmehopa UA, Swaab DF, Lammers GJ. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. Journal of Neuroimmunology 2006;174:187-91. [DOI: 10.1016/j.jneuroim.2006.02.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
585 Quinnell TG, Smith IE. Narcolepsy, idiopathic hypersomnolence and related conditions. Clin Med (Lond) 2011;11:282-6. [PMID: 21902087 DOI: 10.7861/clinmedicine.11-3-282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
586 Tesoriero C, Codita A, Zhang MD, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljeström P, Hökfelt TG, Bentivoglio M, Kristensson K. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 2016;113:E368-77. [PMID: 26668381 DOI: 10.1073/pnas.1521463112] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
587 Chiu CN, Prober DA. Regulation of zebrafish sleep and arousal states: current and prospective approaches. Front Neural Circuits 2013;7:58. [PMID: 23576957 DOI: 10.3389/fncir.2013.00058] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
588 Liu J, Merkle FT, Gandhi AV, Gagnon JA, Woods IG, Chiu CN, Shimogori T, Schier AF, Prober DA. Evolutionarily conserved regulation of hypocretin neuron specification by Lhx9. Development 2015;142:1113-24. [PMID: 25725064 DOI: 10.1242/dev.117424] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
589 De la Herrán-Arita AK, García-García F. Narcolepsy as an immune-mediated disease. Sleep Disord 2014;2014:792687. [PMID: 24551456 DOI: 10.1155/2014/792687] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
590 Kornum BR, Kawashima M, Faraco J, Lin L, Rico TJ, Hesselson S, Axtell RC, Kuipers H, Weiner K, Hamacher A, Kassack MU, Han F, Knudsen S, Li J, Dong X, Winkelmann J, Plazzi G, Nevsimalova S, Hong SC, Honda Y, Honda M, Högl B, Ton TG, Montplaisir J, Bourgin P, Kemlink D, Huang YS, Warby S, Einen M, Eshragh JL, Miyagawa T, Desautels A, Ruppert E, Hesla PE, Poli F, Pizza F, Frauscher B, Jeong JH, Lee SP, Strohl KP, Longstreth WT Jr, Kvale M, Dobrovolna M, Ohayon MM, Nepom GT, Wichmann HE, Rouleau GA, Gieger C, Levinson DF, Gejman PV, Meitinger T, Peppard P, Young T, Jennum P, Steinman L, Tokunaga K, Kwok PY, Risch N, Hallmayer J, Mignot E. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011;43:66-71. [PMID: 21170044 DOI: 10.1038/ng.734] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
591 Jones BE. Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems. Ann N Y Acad Sci 2008;1129:26-34. [PMID: 18591466 DOI: 10.1196/annals.1417.026] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
592 Pollmächer T, Dalal MA, Schuld A. Immunoendocrine Abnormalities in Narcolepsy. Sleep Medicine Clinics 2007;2:293-302. [DOI: 10.1016/j.jsmc.2007.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
593 Thompson MD, Comings DE, Abu-ghazalah R, Jereseh Y, Lin L, Wade J, Sakurai T, Tokita S, Yoshida T, Tanaka H, Yanagisawa M, Burnham WM, Moldofsky H. Variants of theorexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am J Med Genet 2004;129B:69-75. [DOI: 10.1002/ajmg.b.30047] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
594 Cid-pellitero ED, Garzon M. Hypocretin1/OrexinA Axon Targeting of Laterodorsal Tegmental Nucleus Neurons Projecting to the Rat Medial Prefrontal Cortex. Cerebral Cortex 2011;21:2762-73. [DOI: 10.1093/cercor/bhr070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
595 Barateau L, Liblau R, Peyron C, Dauvilliers Y. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS Drugs 2017;31:821-34. [DOI: 10.1007/s40263-017-0464-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
596 Fadel J, Pasumarthi R, Reznikov LR. Stimulation of cortical acetylcholine release by orexin A. Neuroscience 2005;130:541-7. [PMID: 15664710 DOI: 10.1016/j.neuroscience.2004.09.050] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
597 Yamanaka A, Muraki Y, Ichiki K, Tsujino N, Kilduff TS, Goto K, Sakurai T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J Neurophysiol 2006;96:284-98. [PMID: 16611835 DOI: 10.1152/jn.01361.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
598 Bassetti CL, Baumann CR, Dauvilliers Y, Croyal M, Robert P, Schwartz J. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin: CSF histamine and sleepiness/narcolepsy. Journal of Sleep Research 2010;19:620-3. [DOI: 10.1111/j.1365-2869.2010.00819.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
599 Fronczek R, van Geest S, Frölich M, Overeem S, Roelandse FW, Lammers GJ, Swaab DF. Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiol Aging. 2012;33:1642-1650. [PMID: 21546124 DOI: 10.1016/j.neurobiolaging.2011.03.014] [Cited by in Crossref: 130] [Cited by in F6Publishing: 120] [Article Influence: 11.8] [Reference Citation Analysis]
600 Iio K, Saitoh T, Ohshita R, Hino T, Amezawa M, Takayama Y, Nagumo Y, Yamamoto N, Kutsumura N, Irukayama-tomobe Y, Ishikawa Y, Tanimura R, Yanagisawa M, Nagase H. Discovery of Orexin 2 Receptor Selective and Dual Orexin Receptor Agonists based on the Tetralin Structure: Switching of Receptor Selectivity by Chirality on the Tetralin Ring. Bioorganic & Medicinal Chemistry Letters 2022. [DOI: 10.1016/j.bmcl.2022.128555] [Reference Citation Analysis]
601 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla. J Neurophysiol 2002;87:2480-9. [PMID: 11976385 DOI: 10.1152/jn.2002.87.5.2480] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
602 Heidmann B, Gatfield J, Roch C, Treiber A, Tortoioli S, Brotschi C, Williams JT, Bolli MH, Abele S, Sifferlen T, Jenck F, Boss C. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach. ChemMedChem 2016;11:2132-46. [DOI: 10.1002/cmdc.201600175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
603 Song J, Kim E, Kim CH, Song HT, Lee JE. The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain 2015;8:16. [PMID: 25884812 DOI: 10.1186/s13041-015-0106-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
604 Miyagawa T, Tokunaga K. Genetics of narcolepsy. Hum Genome Var 2019;6:4. [PMID: 30652006 DOI: 10.1038/s41439-018-0033-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
605 Fabris C, Cozzi B, Hay-schmidt A, Naver B, Møller M. Demonstration of an orexinergic central innervation of the pineal gland of the pig: Orexinergic System in the Pig Brain. J Comp Neurol 2004;471:113-27. [DOI: 10.1002/cne.20007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
606 Pelayo R, Hodgson N, Guilleminault C. Chapter 34 The history of sleep medicine. History of Neurology. Elsevier; 2009. pp. 547-56. [DOI: 10.1016/s0072-9752(08)02134-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
607 Mintz EM, van den Pol AN, Casano AA, Albers H. Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus). Journal of Chemical Neuroanatomy 2001;21:225-38. [DOI: 10.1016/s0891-0618(01)00111-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
608 Monaca C, Franco P, Philip P, Dauvilliers Y. French consensus. Type 1 and type 2 Narcolepsy: Investigations and follow-up. Revue Neurologique 2017;173:25-31. [DOI: 10.1016/j.neurol.2016.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
609 Chokroverty S. Overview of Normal Sleep. In: Chokroverty S, editor. Sleep Disorders Medicine. New York: Springer; 2017. pp. 5-27. [DOI: 10.1007/978-1-4939-6578-6_2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
610 Wurtman RJ. Narcolepsy and the hypocretins. Metabolism 2006;55:S36-9. [DOI: 10.1016/j.metabol.2006.07.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
611 Kumar S, Szymusiak R, Bashir T, Suntsova N, Rai S, McGinty D, Alam MN. Inactivation of median preoptic nucleus causes c-Fos expression in hypocretin- and serotonin-containing neurons in anesthetized rat. Brain Res 2008;1234:66-77. [PMID: 18722360 DOI: 10.1016/j.brainres.2008.07.115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
612 Hirtz C, Vialaret J, Gabelle A, Nowak N, Dauvilliers Y, Lehmann S. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci Rep 2016;6:25162. [PMID: 27165941 DOI: 10.1038/srep25162] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
613 Baier PC, Hallschmid M, Seeck-Hirschner M, Weinhold SL, Burkert S, Diessner N, Göder R, Aldenhoff JB, Hinze-Selch D. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med 2011;12:941-6. [PMID: 22036605 DOI: 10.1016/j.sleep.2011.06.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
614 de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
615 Inocente CO, Lavault S, Lecendreux M, Dauvilliers Y, Reimao R, Gustin MP, Castets S, Spiegel K, Lin JS, Arnulf I, Franco P. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013;19:521-8. [PMID: 23574649 DOI: 10.1111/cns.12105] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
616 Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23:1-15. [PMID: 11844742 DOI: 10.1210/edrv.23.1.0454] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
617 Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ. Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014;13:461-71. [PMID: 24680372 DOI: 10.1016/S1474-4422(14)70053-5] [Cited by in Crossref: 183] [Cited by in F6Publishing: 60] [Article Influence: 22.9] [Reference Citation Analysis]
618 Sviatkó K, Hangya B. Monitoring the Right Collection: The Central Cholinergic Neurons as an Instructive Example. Front Neural Circuits 2017;11:31. [PMID: 28496401 DOI: 10.3389/fncir.2017.00031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
619 Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A, Matsui T, Muraoka H, Ishizuka Y, Kanba S, Sakurai T. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 2002;318:61-4. [PMID: 11796186 DOI: 10.1016/s0304-3940(01)02476-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
620 Yokogawa T, Marin W, Faraco J, Pézeron G, Appelbaum L, Zhang J, Rosa F, Mourrain P, Mignot E. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol 2007;5:e277. [PMID: 17941721 DOI: 10.1371/journal.pbio.0050277] [Cited by in Crossref: 237] [Cited by in F6Publishing: 220] [Article Influence: 16.9] [Reference Citation Analysis]
621 Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54. [PMID: 15070772 DOI: 10.1073/pnas.0400590101] [Cited by in Crossref: 217] [Cited by in F6Publishing: 193] [Article Influence: 12.1] [Reference Citation Analysis]
622 Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, Julkunen I, Vuorela A, Vaarala O, Nohynek H, Pasini FL, Montomoli E, Trombetta C, Adams CM, Rothbard J, Steinman L. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015;7:294ra105. [PMID: 26136476 DOI: 10.1126/scitranslmed.aab2354] [Cited by in Crossref: 159] [Cited by in F6Publishing: 132] [Article Influence: 26.5] [Reference Citation Analysis]
623 Kopp N, Climer S, Dougherty JD. Moving from capstones toward cornerstones: successes and challenges in applying systems biology to identify mechanisms of autism spectrum disorders. Front Genet 2015;6:301. [PMID: 26500678 DOI: 10.3389/fgene.2015.00301] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
624 Li T, Xu W, Ouyang J, Lu X, Sherchan P, Lenahan C, Irio G, Zhang JH, Zhao J, Zhang Y, Tang J. Orexin A alleviates neuroinflammation via OXR2/CaMKKβ/AMPK signaling pathway after ICH in mice. J Neuroinflammation 2020;17:187. [PMID: 32539736 DOI: 10.1186/s12974-020-01841-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
625 Lo Martire V, Silvani A, Bastianini S, Berteotti C, Zoccoli G. Effects of ambient temperature on sleep and cardiovascular regulation in mice: the role of hypocretin/orexin neurons. PLoS One 2012;7:e47032. [PMID: 23056568 DOI: 10.1371/journal.pone.0047032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
626 So M, Hashimoto H, Saito R, Yamamoto Y, Motojima Y, Ueno H, Sonoda S, Yoshimura M, Maruyama T, Kusuhara K, Ueta Y. Inhibition of ghrelin-induced feeding in rats by pretreatment with a novel dual orexin receptor antagonist. J Physiol Sci 2018;68:129-36. [PMID: 28054308 DOI: 10.1007/s12576-016-0517-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
627 Broberger C. Brain regulation of food intake and appetite: molecules and networks. J Intern Med 2005;258:301-27. [DOI: 10.1111/j.1365-2796.2005.01553.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 143] [Article Influence: 10.1] [Reference Citation Analysis]
628 Shiba T, Ozu M, Yoshida Y, Mignot E, Nishino S. Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate. Biochem Biophys Res Commun 2002;294:615-20. [PMID: 12056812 DOI: 10.1016/S0006-291X(02)00521-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
629 Tsunematsu T, Tabuchi S, Tanaka KF, Boyden ES, Tominaga M, Yamanaka A. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice. Behav Brain Res 2013;255:64-74. [PMID: 23707248 DOI: 10.1016/j.bbr.2013.05.021] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
630 Sakurai T. Orexin deficiency and narcolepsy. Curr Opin Neurobiol 2013;23:760-6. [PMID: 23663890 DOI: 10.1016/j.conb.2013.04.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
631 Xu X, Wu H, Zhuang J, Chen K, Huang B, Zhao Z, Zhao Z. Sleep-wake patterns, non-rapid eye movement, and rapid eye movement sleep cycles in teenage narcolepsy. Sleep Med 2017;33:47-56. [PMID: 28449905 DOI: 10.1016/j.sleep.2016.08.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
632 Shukla C, Basheer R. Metabolic signals in sleep regulation: recent insights. Nat Sci Sleep 2016;8:9-20. [PMID: 26793010 DOI: 10.2147/NSS.S62365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
633 Gao XB, van den Pol AN. Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J Physiol 2001;533:237-52. [PMID: 11351031 DOI: 10.1111/j.1469-7793.2001.0237b.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 138] [Article Influence: 6.4] [Reference Citation Analysis]
634 Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
635 Lee SH, Dan Y. Neuromodulation of brain states. Neuron 2012;76:209-22. [PMID: 23040816 DOI: 10.1016/j.neuron.2012.09.012] [Cited by in Crossref: 323] [Cited by in F6Publishing: 271] [Article Influence: 32.3] [Reference Citation Analysis]
636 Milbank E, López M. Orexins/Hypocretins: Key Regulators of Energy Homeostasis. Front Endocrinol (Lausanne) 2019;10:830. [PMID: 31920958 DOI: 10.3389/fendo.2019.00830] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
637 Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Naghdi N, Yanai K. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005;118:254-62. [DOI: 10.1016/j.pain.2005.08.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
638 Dalal MA, Schuld A, Beitinger P, Bubendorff V, Pollmacher T. Neuroendocrine and Metabolic Aspects of Narcolepsy. Neuroendokrine und metabolische Aspekte der Narkolepsie. Somnologie 2002;6:95-100. [DOI: 10.1046/j.1439-054x.2002.02193.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
639 Chokroverty S. An Overview of Normal Sleep. Sleep Disorders Medicine. Elsevier; 2009. pp. 5-21. [DOI: 10.1016/b978-0-7506-7584-0.00002-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
640 Quaedackers L, Pillen S, Overeem S. Recognizing the Symptom Spectrum of Narcolepsy to Improve Timely Diagnosis: A Narrative Review. Nat Sci Sleep 2021;13:1083-96. [PMID: 34262379 DOI: 10.2147/NSS.S278046] [Reference Citation Analysis]
641 Tsai TF, Crucitti A, Nacci P, Nicolay U, Della Cioppa G, Ferguson J, Clemens R. Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scand J Infect Dis 2011;43:702-6. [PMID: 21534891 DOI: 10.3109/00365548.2011.580777] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
642 Luciano M, Zhu G, Kirk KM, Gordon SD, Heath AC, Montgomery GW, Martin NG. "No thanks, it keeps me awake": the genetics of coffee-attributed sleep disturbance. Sleep 2007;30:1378-86. [PMID: 17969472 DOI: 10.1093/sleep/30.10.1378] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
643 Kuroki C, Takahashi Y, Ootsuka Y, Kanmura Y, Kuwaki T. The Impact of Hypothermia on Emergence from Isoflurane Anesthesia in Orexin Neuron-Ablated Mice. Anesthesia & Analgesia 2013;116:1001-5. [DOI: 10.1213/ane.0b013e31828842f0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
644 Doghramji PP. Integrating Modern Concepts of Insomnia and its Contemporary Treatment into Primary Care. Postgraduate Medicine 2015;126:82-101. [DOI: 10.3810/pgm.2014.09.2802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
645 Swaab DF. Neuropeptides in hypothalamic neuronal disorders. Int Rev Cytol 2004;240:305-75. [PMID: 15548416 DOI: 10.1016/S0074-7696(04)40003-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
646 Chase MH. A unified survival theory of the functioning of the hypocretinergic system. J Appl Physiol (1985) 2013;115:954-71. [PMID: 23640599 DOI: 10.1152/japplphysiol.00700.2012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
647 Tsai KL, Clark LA, Murphy KE. Understanding hereditary diseases using the dog and human as companion model systems. Mamm Genome. 2007;18:444-451. [PMID: 17653794 DOI: 10.1007/s00335-007-9037-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
648 Wise MS, Lynch J. Narcolepsy in children. Semin Pediatr Neurol 2001;8:198-206. [PMID: 11768782 DOI: 10.1053/spen.2001.29475] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
649 Inutsuka A, Yamanaka A. The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. Front Endocrinol (Lausanne) 2013;4:18. [PMID: 23508038 DOI: 10.3389/fendo.2013.00018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 9.8] [Reference Citation Analysis]
650 Xie X(. The Neuronal Circuit Between Nociceptin/Orphanin FQ and Hypocretins/Orexins Coordinately Modulates Stress-Induced Analgesia and Anxiety-Related Behavior. Nociceptin Opioid. Elsevier; 2015. pp. 295-321. [DOI: 10.1016/bs.vh.2014.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
651 Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 2009;32:993-8. [PMID: 19725250 DOI: 10.1093/sleep/32.8.993] [Cited by in Crossref: 154] [Cited by in F6Publishing: 123] [Article Influence: 11.8] [Reference Citation Analysis]
652 Ebrahim IO, Howard RS, Kopelman MD, Sharief MK, Williams AJ. The Hypocretin/Orexin System. J R Soc Med 2002;95:227-30. [DOI: 10.1177/014107680209500503] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
653 Oganesyan GA, Titkov ES, Zhernovaya NN. Development of clinical somnology (Contibution of I.G. Karmanova). J Evol Biochem Phys 2016;52:168-72. [DOI: 10.1134/s0022093016020071] [Reference Citation Analysis]
654 Douglass AB. Narcolepsy: Differential Diagnosis or Etiology in Some Cases of Bipolar Disorder and Schizophrenia? CNS spectr 2003;8:120-6. [DOI: 10.1017/s1092852900018344] [Cited by in Crossref: 28] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
655 Petrovický P, Němcová V, ten Donkelaar HJ, Overeem S, Vos P. The Reticular Formation and Some Related Nuclei. Clinical Neuroanatomy. Berlin: Springer Berlin Heidelberg; 2011. pp. 211-47. [DOI: 10.1007/978-3-642-19134-3_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
656 Zhang D, Perrey DA, Decker AM, Langston TL, Mavanji V, Harris DL, Kotz CM, Zhang Y. Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists. J Med Chem 2021;64:8806-25. [PMID: 34101446 DOI: 10.1021/acs.jmedchem.1c00841] [Reference Citation Analysis]
657 Gavrilov YV, Ellison BA, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE, Valko PO. Disrupted Sleep in Narcolepsy: Exploring the Integrity of Galanin Neurons in the Ventrolateral Preoptic Area. Sleep 2016;39:1059-62. [PMID: 26951397 DOI: 10.5665/sleep.5754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
658 Brooks S, Black J. Novel therapies for narcolepsy. Expert Opinion on Investigational Drugs 2005;11:1821-7. [DOI: 10.1517/13543784.11.12.1821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
659 Bastianini S, Silvani A, Berteotti C, Lo Martire V, Cohen G, Ohtsu H, Lin JS, Zoccoli G. Histamine Transmission Modulates the Phenotype of Murine Narcolepsy Caused by Orexin Neuron Deficiency. PLoS One 2015;10:e0140520. [PMID: 26474479 DOI: 10.1371/journal.pone.0140520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
660 Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-8. [PMID: 11558795 DOI: 10.1002/ana.1130] [Cited by in Crossref: 308] [Cited by in F6Publishing: 261] [Article Influence: 14.7] [Reference Citation Analysis]
661 Quaedackers L, van Gilst MM, van Mierlo P, Lammers GJ, Dhondt K, Amesz P, Peeters E, Hendriks D, Vandenbussche N, Pillen S, Overeem S. Impaired social functioning in children with narcolepsy. Sleep 2019;42. [PMID: 30476304 DOI: 10.1093/sleep/zsy228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
662 Nakabayashi M, Suzuki T, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Date F, Takeyama J, Darnel AD, Moriya T, Sasano H. Orexin-A expression in human peripheral tissues. Molecular and Cellular Endocrinology 2003;205:43-50. [DOI: 10.1016/s0303-7207(03)00206-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
663 Weiner Lachmi K, Lin L, Kornum BR, Rico T, Lo B, Aran A, Mignot E. DQB1*06:02 allele-specific expression varies by allelic dosage, not narcolepsy status. Hum Immunol 2012;73:405-10. [PMID: 22326585 DOI: 10.1016/j.humimm.2012.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
664 Dauvilliers Y, Tafti M. Molecular genetics and treatment of narcolepsy. Ann Med 2006;38:252-62. [PMID: 16754256 DOI: 10.1080/07853890500489700] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
665 Tafti M, Dauvilliers Y. Pharmacogenomics in the treatment of narcolepsy. Pharmacogenomics 2003;4:23-33. [PMID: 12517283 DOI: 10.1517/phgs.4.1.23.22590] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
666 Sutcliffe JG, de Lecea L. Not asleep, not quite awake. Nat Med 2004;10:673-4. [DOI: 10.1038/nm0704-673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
667 Kaneko Y, Kanbayashi T, Arii J, Kondo H, Kubota H, Hayashi-ogawa Y, Miyakoshi N, Yano T, Mishima K, Shimizu T. CSF hypocretin-1 measurement in pediatric and teenage patients with sleep disorders. Sleep and Biological Rhythms 2006;4:186-9. [DOI: 10.1111/j.1479-8425.2006.00217.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
668 España RA, McCormack SL, Mochizuki T, Scammell TE. Running promotes wakefulness and increases cataplexy in orexin knockout mice. Sleep 2007;30:1417-25. [PMID: 18041476 DOI: 10.1093/sleep/30.11.1417] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
669 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
670 Yeh E, Weiss LA. If genetic variation could talk: What genomic data may teach us about the importance of gene expression regulation in the genetics of autism. Mol Cell Probes 2016;30:346-56. [PMID: 27751841 DOI: 10.1016/j.mcp.2016.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
671 Hoesch RE, Koenig MA, Geocadin RG. Coma After Global Ischemic Brain Injury: Pathophysiology and Emerging Therapies. Critical Care Clinics 2008;24:25-44. [DOI: 10.1016/j.ccc.2007.11.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
672 Tafti M, Hor H, Dauvilliers Y, Lammers GJ, Overeem S, Mayer G, Javidi S, Iranzo A, Santamaria J, Peraita-Adrados R, Vicario JL, Arnulf I, Plazzi G, Bayard S, Poli F, Pizza F, Geisler P, Wierzbicka A, Bassetti CL, Mathis J, Lecendreux M, Donjacour CE, van der Heide A, Heinzer R, Haba-Rubio J, Feketeova E, Högl B, Frauscher B, Benetó A, Khatami R, Cañellas F, Pfister C, Scholz S, Billiard M, Baumann CR, Ercilla G, Verduijn W, Claas FH, Dubois V, Nowak J, Eberhard HP, Pradervand S, Hor CN, Testi M, Tiercy JM, Kutalik Z. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014;37:19-25. [PMID: 24381371 DOI: 10.5665/sleep.3300] [Cited by in Crossref: 118] [Cited by in F6Publishing: 103] [Article Influence: 14.8] [Reference Citation Analysis]
673 Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities: Hypocretin release during the sleep-wake cycle. European Journal of Neuroscience 2001;14:1075-81. [DOI: 10.1046/j.0953-816x.2001.01725.x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 278] [Article Influence: 14.5] [Reference Citation Analysis]
674 Schuld A, Beitinger PA, Dalal M, Geller F, Wetter TC, Albert ED, Hebebrand J, Pollmächer T. Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers. Sleep Med 2002;3:335-9. [PMID: 14592196 DOI: 10.1016/s1389-9457(02)00012-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
675 Campion D. Dissection génétique des maladies à hérédité complexe. Med Sci (Paris) 2001;17:1139-48. [DOI: 10.1051/medsci/200117111139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
676 Kreier F, Swaab DF. History of hypothalamic research: "The spring of primitive existence". Handb Clin Neurol 2021;179:7-43. [PMID: 34225985 DOI: 10.1016/B978-0-12-819975-6.00031-5] [Reference Citation Analysis]
677 Mignot EJ. History of narcolepsy at Stanford University. Immunol Res 2014;58:315-39. [PMID: 24825774 DOI: 10.1007/s12026-014-8513-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
678 Brundin L, Björkqvist M, Petersén Å, Träskman-bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. European Neuropsychopharmacology 2007;17:573-9. [DOI: 10.1016/j.euroneuro.2007.01.005] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 8.5] [Reference Citation Analysis]
679 Fronczek R, Verschuuren J, Lammers GJ. Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol 2007;254:1607-8. [DOI: 10.1007/s00415-007-0594-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
680 Seifinejad A, Li S, Mikhail C, Vassalli A, Pradervand S, Arribat Y, Pezeshgi Modarres H, Allen B, John RM, Amati F, Tafti M. Molecular codes and in vitro generation of hypocretin and melanin concentrating hormone neurons. Proc Natl Acad Sci U S A 2019;116:17061-70. [PMID: 31375626 DOI: 10.1073/pnas.1902148116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
681 Muehlan C, Brooks S, Zuiker R, van Gerven J, Dingemanse J. Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration. European Neuropsychopharmacology 2019;29:847-57. [DOI: 10.1016/j.euroneuro.2019.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
682 Williams RH, Black SW, Thomas AM, Piquet J, Cauli B, Kilduff TS. Excitation of Cortical nNOS/NK1R Neurons by Hypocretin 1 is Independent of Sleep Homeostasis. Cereb Cortex 2019;29:1090-108. [PMID: 29462275 DOI: 10.1093/cercor/bhy015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
683 Miskolzie M, Lucyk S, Kotovych G. NMR Conformational Studies of Micelle-Bound Orexin-B: A Neuropeptide Involved in the Sleep/Awake Cycle and Feeding Regulation. Journal of Biomolecular Structure and Dynamics 2003;21:341-51. [DOI: 10.1080/07391102.2003.10506930] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
684 Yelin-Bekerman L, Elbaz I, Diber A, Dahary D, Gibbs-Bar L, Alon S, Lerer-Goldshtein T, Appelbaum L. Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a. Elife 2015;4:e08638. [PMID: 26426478 DOI: 10.7554/eLife.08638] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
685 Jöhren O, Brüggemann N, Dendorfer A, Dominiak P. Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors. Endocrinology 2003;144:1219-25. [DOI: 10.1210/en.2002-0030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
686 Campos-Beltrán D, Marshall L. Changes in sleep EEG with aging in humans and rodents. Pflugers Arch 2021;473:841-51. [PMID: 33791849 DOI: 10.1007/s00424-021-02545-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
687 Ortega JE, Katner J, Davis R, Wade M, Nisenbaum L, Nomikos GG, Svensson KA, Perry KW. Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: a microdialysis study. J Neurosci Res 2012;90:588-96. [PMID: 22038504 DOI: 10.1002/jnr.22781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
688 Sakai N, Matsumura M, Lin L, Mignot E, Nishino S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci Rep 2019;9:477. [PMID: 30679597 DOI: 10.1038/s41598-018-36942-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
689 de Martin Truzzi G, Naufel MF, Tufik S, Coelho FM. The influence of narcolepsy on olfactory function: a review. Sleep Med 2020;72:75-81. [PMID: 32554327 DOI: 10.1016/j.sleep.2020.03.023] [Reference Citation Analysis]
690 Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
691 Luppi PH. Jouvet's animal model of RBD, clinical RBD, and their relationships to REM sleep mechanisms. Sleep Med 2018;49:28-30. [PMID: 30172630 DOI: 10.1016/j.sleep.2018.05.026] [Reference Citation Analysis]
692 de Biase S, Pellitteri G, Gigli GL, Valente M. Evaluating pitolisant as a narcolepsy treatment option. Expert Opin Pharmacother 2021;22:155-62. [PMID: 32941089 DOI: 10.1080/14656566.2020.1817387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
693 Alam MN, Gong H, Alam T, Jaganath R, McGinty D, Szymusiak R. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol. 2002;538:619-631. [PMID: 11790824 DOI: 10.1113/jphysiol.2001.012888] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 6.5] [Reference Citation Analysis]
694 Donjacour CE, Aziz NA, Overeem S, Kalsbeek A, Pijl H, Lammers GJ. Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study. Sleep 2014;37:795-801. [PMID: 24899766 DOI: 10.5665/sleep.3592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
695 Kalsbeek A, Yi CX, La Fleur SE, Fliers E. The hypothalamic clock and its control of glucose homeostasis. Trends Endocrinol Metab 2010;21:402-10. [PMID: 20303779 DOI: 10.1016/j.tem.2010.02.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
696 Jensen JB, Sorensen HB, Kempfner J, Sørensen GL, Knudsen S, Jennum P. Sleep-wake transition in narcolepsy and healthy controls using a support vector machine. J Clin Neurophysiol 2014;31:397-401. [PMID: 25271675 DOI: 10.1097/WNP.0000000000000074] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
697 Kripke DF. Is suvorexant a better choice than alternative hypnotics? F1000Res 2015;4:456. [PMID: 26594338 DOI: 10.12688/f1000research.6845.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
698 Oyiengo D, Louis M, Hott B, Bourjeily G. Sleep disorders in pregnancy. Clin Chest Med 2014;35:571-87. [PMID: 25156772 DOI: 10.1016/j.ccm.2014.06.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
699 Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep–wake disorders. The Lancet Neurology 2005;4:673-82. [DOI: 10.1016/s1474-4422(05)70196-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
700 Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005;102:19168-73. [PMID: 16357203 DOI: 10.1073/pnas.0507480102] [Cited by in Crossref: 354] [Cited by in F6Publishing: 361] [Article Influence: 20.8] [Reference Citation Analysis]
701 Ono H, Kanbayashi T, Imanishi A, Ayabe T, Sagawa Y, Tsutsui K, Ohmori Y, Takeshima M, Nishino S, Shimizu T. Clinical characteristics of symptomatic narcolepsy or hypersomnia: an analysis of 182 consecutive cases with neurological disorders associated with hypersomnolence. Sleep Biol Rhythms 2019;17:123-40. [DOI: 10.1007/s41105-018-0186-2] [Reference Citation Analysis]
702 Alvarez CE, Sutcliffe JG. Hypocretin is an early member of the incretin gene family. Neurosci Lett 2002;324:169-72. [PMID: 12009515 DOI: 10.1016/s0304-3940(02)00195-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
703 Waldenlind E, Sjöstrand C. Pathophysiology of cluster headache and other trigeminal autonomic cephalalgias. Headache. Elsevier; 2010. pp. 389-411. [DOI: 10.1016/s0072-9752(10)97033-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
704 Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, Lecendreux M, Lammers GJ, Donjacour CE, Du Pasquier RA, Pfister C, Petit B, Hor H, Mühlethaler M, Tafti M. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9. [PMID: 20160349 DOI: 10.1172/JCI41366] [Cited by in Crossref: 215] [Cited by in F6Publishing: 77] [Article Influence: 17.9] [Reference Citation Analysis]
705 Nguyen XH, Dauvilliers Y, Quériault C, Perals C, Romieu-Mourez R, Paulet PE, Bernard-Valnet R, Fazilleau N, Liblau R. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun 2018;94:134-42. [PMID: 30104107 DOI: 10.1016/j.jaut.2018.07.021]